1998年1999年2000年2001年2002年
2003年2004年2005年2006年2007年
2008年2009年2010年2011年2012年
2013年2014年2015年2016年2017年
2018年2019年2020年2021年

2021

1. Kimura N, Kawahara T, Uemura Y, Atsumi T, Sumida T, Mimura T, Kawaguchi Y, Amano H, Iwasaki Y, Kaneko Y, Matsui T, Muro Y, Imura Y, Kanda T, Tanaka Y, Kawakami A, Jinnin M, Ishii T, Hiromura K, Miwa Y, Nakajima H, Kuwana M, Nishioka Y, Morinobu A, Kameda H, Kohsaka H.:
   Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-center, randomized controlled trial.
   Rheumatology (Oxford) (in press)
   
   
2. Abe S, Tsuboi H, Toko H, Honda F, Yagishita M, Hagiwara S, Kondo Y, Konishi R, Okune M, Ichimura Y, Okiyama N, Matsumoto I.:
   Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody.
   Rheumatol Adv Pract 5(3),2021
   
   
3. Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N.:
   Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties.
   J Dermatol (in press)
   
   
4. Kitanaga Y, Yamajuku D, Kubo S, Nakamura K, Maeda M, Seki M, Kaneko Y, Kinugasa F, Morokata T, Kondo Y, Yoshinari H, Nakayamada S, Sumida T, Tanaka Y.:
   Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosus.
   Int Immunopharmacol (in press)
   
   
5. Furuyama K, Kondo Y, Shimizu M, Yokosawa M, Segawa S, Iizuka A, Tanimura R, Tsuboi H, Matsumoto I, Sumida T.:
   RORγt⁺Foxp3⁺ regulatory T cells in the regulation of autoimmune arthritis.
   Clin Exp Immunol (in press)
   
   
6. Shimizu M, Kondo Y, Tanimura R, Furuyama K, Yokosawa M, Asashima H, Tsuboi H, Matsumoto I, Sumida T.:
   T-bet represses collagen-induced arthritis by suppressing Th17 lineage commitment through inhibition of RORgt expression and function.
   Sci Rep (in press)
   
   
7. Honda F, Tsuboi H, Ono Y, Abe S, Takahashi H, Ito K, Yamada K, Kawano M, Kondo Y, Asano K, Tanaka M, Mallsen M, Mallsen B, Matsumoto I, Sumida T.:
   Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis.
   Arthritis Res Ther (in press)
   
   
8. Ohyama A, Osada A, Kawaguchi H, Kurata I, Nishiyama T, Iwai T, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
   Specific increase in joint neutrophil extracellular traps and its relation to interleukin 6 in autoimmune arthritis.
   Int J Mol Sci (in press)
   
   
9. Kurata I, Mikami N, Ohyama A, Osada A, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
   Impaired function of PD-1+ follicular regulatory T cells in systemic lupus erythematosus.
   Clin Exp Immunol (in press)
   
   
10. Shimoyama S, Nakagawa I, Jiang JJ, Matsumoto I, Chiorini JA, Hasegawa Y, Ohara O, Hasebe R, Ota M, Uchida M, Kamimura D, Hojyo S, Tanaka Y, Atsumi T, Murakami M.:
    Sjogren's syndrome-associated SNPs increase GTF2I expression in salivary gland cells to enhance inflammation development.
    Int Immunol (in press)
    
    
11. Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N.:
    Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
    Rheumatology (Oxford) (in press)
    
    
12. Okamoto S, Tsuboi H, Noma H, Tabuchi D, Sugita T, Nishiyama T, Terasaki T, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
    Predictive factors for pneumomediastinum during management of connective tissue diseaserelated interstitial lung disease: A retrospective study.
    Intern Med (in press)
    
    
13. Okamoto S, Kondo Y, Sato K, Nishiyama T, Toko H, Yagishita M, Yokosawa M, Tsuboi H, Ieda M, Matsumoto I.:
    Anti-PL-7 antibody positive antisynthetase syndrome diagnosed after the onset of pulmonary hypertension and right-sided heart failure.
    Rheumatology(Oxford) 60(8):e277-e279,2021
    
    
14. Takahashi H, Tsuboi H, Abe S, Honda F, Kondo Y, Matsumoto I, Sumida T.:
    Humanized NOD/SCID/IL2rγnull mice exhibit functionally augmented human regulatory T cells associated with enzymatic upregulation of H3K27me3 in comparison with humans.
    Clin Exp Immunol 204(2):239-250,2021
    
    
15. Nishiyama T, Kondo Y, Tsuboi H, Noma H, Tabuchi D, Sugita T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Yagishita M, Abe S, Takahashi H, Osada A, Hagiwara S, Matsumoto I, Sumida T.:
    QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
    Mod Rheumatol (in press)
    
    
16. Morinaka S, Tsuboi H, Hagiwara S, Sugita T, Tabuchi D, Sato R, Nishiyama T, Okamoto S, Terasaki T, Yagishita M, Takahashi H, Kondo Y, Matsumoto I, Sumida T.:
    Clinical features of large vessel vasculitis (LVV): Elderly-onset versus young-onset.
    Mod Rheumatol (in press)
    
    
17. Osada A, Matsumoto I, Mikami N, Ohyama A, Kurata I, Kondo Y, Tsuboi H, Ishigami A, Sano Y, Arai T, Ise N, Sumida T.:
    Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
    Clin Exp Immunol 203(3):385-399,2021
    
    
18. Tsuboi T, Suzuki H, Akutsu D, Terasaki T, Okamoto S, Kondo Y, Matsumoto I, Mizokami Y, Sumida T.:
    The pathologically confirmed esophageal involvement of idiopathic multicentric Castleman’s disease mimicking early esophageal cancer.
    Rheumatology(Oxford) 60(2):e50-e52,2021
    
    
19. Yagishita M, Tsuboi H, Tabuchi D, Sugita T, Nishiyama T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
    Clinical features and prognosis of nocardiosis in patients with connective tissue diseases.
    Mod Rheumatol 31(3):636-642,2021
    
    
20. Kurata I, Matsumoto I, Sumida T.:
    T follicular helper cell subsets: a potential key player in autoimmunity.
    Immunol Med 44(1):1-9,2021
    
    
21. Terasaki M, Takahashi H, Sato R, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
    Successful treatment with multitarget therapy of mycophenolate mofetil and tacrolimus for cyclophosphamide-resistant ANCA-associated pauci-immune glomerulonephritis developed independently of systemic lupus erythematosus.
    J Clin Rheumatol 27(2):e79-e80,2021
    
    
22. Sato R, Takahashi H, Terasaki M, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
    Advantage of magnetic resonance imaging in detecting tracheal involvement and evaluation of the therapeutic effect in relapsing polychondritis with asthma-like symptoms.
    J Clin Rheumatol 27(3):e90-e91,2021
    
    

2020

1. Yin X, Kim K, Suetsugu H, Bang S-Y, Wen L, Koido M, Ha E, Liu L, Sakamoto Y, Jo S, Leng R-X, Otomo N, Laurynenka V, Kwon Y-C, Sheng Y, Sugano N, Hwang M-Y, Li W, Mukai M, Yoon K, Cai M, Ishigaki K, Chung W-T, Huang H, Takahashi D, Lee S-S, Wang M, Karino K, Shim S-C, Zheng X, Miyamura T, Kang Y-M, Ye D, Nakamura J, Suh C-H, Tang Y, Motomura G, Park Y-B, Ding H, Kuroda T, Choe J-Y, Li C, Niiro H, Park Y, Shen C, Miyamoto T, Ahn G-Y, Fei W, Takeuchi T, Shin J-M, Li K, Kawaguchi Y, Lee Y-K, Wang Y, Amano K, Yang W, Tada Y, Yamji K, Shimizu M, Atsumi T, Suzuki A, Sumida T, Okada Y, Matsuda K, Matsuo K, Kochi Y, Japanese Reseatch Committee on Idiopathic Osteonecrosis og the Femoral Head, Kottyan L-C, Weirauch M-T, Parameswaran S, Eswar S, Hanan S, Chen X, Yamamoto K, Harley J-B, Ohmura K, Kim T-H, Yang S, Yamamoto T, Kim B-J, Shen N, Ikegawa S, Lee H-S, Zhang X, Terao C, Cui Y, Bae S-C.:
   Meta-analysis of 208,370 East Asians identifies 113 genomic loci and yields new non-immune cell relevant biological insights for systemic lupus erythematosus.
   Ann Rheum Dis 80(5):632-40,2020
   
   
2. Baer A-N, Gottenberg J-E, Clar E-W, Sumida T, Takeuchi T, Seror R, Foulks, G, Nys M, Mukherjee S, Wong R, Ray N, Boostsma H.:
   Efficacy and safety of abatacept in active primary Sjogren's syndrome: results of a phase III, randomised, placebo-controlled trial.
   Ann Rheum Dis 80(3):339-348,2020
   
   
3. Kawasaki A, Namba N, Sada K, Hirano F, Kobayashi S, Nagasaka K, Sugihara T, Ono N, Fujimoto T, Kusaoi M, Tamura N, Yamagata K, Sumida T, Hashimoto H, Ozaki S, Makino H, Arimura Y, Harigai M, Tsuchiya N.:
   Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study.
   Arthritis Res Ther 22(1):246,2020
   
   
4. Terasaki T, Kondo Y, Takahashi M, Tawara T, Fujita A, Yagi H, Kawai H, Noguchi M, Sato R, Terasaki M, Okamoto S,
   Toko H, Yagishita M, Takahashi H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
   Therapeutic plasma exchange improved pregnancy-associated thrombotic microangiopathy but not pregnancy outcome in patient with systemic lupus erythematosus.
   Intern Med 59(24):3235-3238,2020
   
   
5. Abe S, Tsuboi H, Kudo H, Asashima H, Ono Y, Honda F, Takahashi H, Yagishita M, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
   Identification of M3 muscarinic acetylcholine receptor reactive Th17 cells in patients with primary Sjogren's syndrome.
   JCI insight 5(15):e135982,2020
   
   
6. Yamashita K, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Okiyama N, Nagaoka S, Shimada K, Sugai S, Katayama M, Hirohata S, Okamoto A, Chiba N, Suematsu E, Setoguchi K, Migita K, Sumida T, Tohma S, Hamaguchi Y, Hasegawa M, Sato S, Kawaguchi Y, Takehara K, Tsuchiya N.:
   Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis.
   Rheumatology(Oxford) 59(11):3553-3562,2020
   
   
7. Okamoto S, Tsuboi H, Sato R, Terasaki T, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
   IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review.
   Rheumatol Int 40(10):1725-1732,2020
   
   
8. Morinaka S, Takano Y, Goto D, Sumida T.:
   Familial HLA-B*52 vasculitis: Maternal, atypical Cogan's syndrome with Takayasu arteritis-mimicking aortitis and filial Takayasu arteritis.
   Intern Med 59(15):1899-1904,2020
   
   
9. Imamura M, Mukaino A, Takamatsu K, Tsuboi H, Higuchi O, Nakamura H, Abe S, Ando Y, Matsuo H, Nakamura T, Sumida T, Kawakami A, Nakane S.:
   Ganglionic acetylcholine receptor antibodies and autonomic dysfunction in autoimmune rheumatic diseases.
   Int J Mol Sci 21(4):1332,2020
   
   
10. Miki H, Tahara-Hanaoka S, Almida MS, Hitomi K, Shibagaki S, Kanemaru K, Lin YH, Iwata K, Miyake S, Shibayama S, Sumida T, Shibuya K, Shibuya A.:
    Allergin-1 immunoreceptor1 suppresses house dust mite-induced allergic airway inflammation.
    J Immunol 204(4):753-762,2020
    
    
11. Ono Y, Tsuboi H, Moriyama M, Asashima H, Kudo H, Takahashi H, Honda F, Abe S, Kondo Y, Takahashi S, Nakamura S, Matsumoto I, Sumida T.:
    RORγt antagonist improves Sjogren's syndrome-like sialadenitis through downregulation of CD25.
    Oral Dis 26(4):766-777,2020
    
    
12. Nishiyama T, Kondo Y, Okamoto S, Terasaki M, Toko H, Yagishita M, Takahashi H, Yokosawa M, Tsuboi H, Matsumoto I, Sumida T.:
    Aortic arch aneurysm in Behcet disease successfully treated with infliximab.
    Intern Med 59(8):1087-1091,2020
    
    
13. Jinnin M, Ohta A, Ishihara S, Amano H, Atsumi T, Fujimoto M, Kanda T, Kawaguchi Y, Kawakami A, Mimori A, Mimori T, Mimura T, Muro Y, Sano H, Shimizu J, Takeuchi T, Tanaka Y, Yamamoto K, Sumida T, Kohsaka H, The Research Team for Autoimmune Disease, The Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare.:
    The first external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR) / American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
    Ann Rheum Dis 79(3):387-392,2020
    
    
14. Kudo H, Tsuboi H, Asashima H, Takahashi H, Ono Y, Abe S, Honda F, Kondo Y, Wakasa Y, Takaiwa F, Takano M, Matsui M, Matsumoto I, Sumida T.:
    Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjogren's syndrome.
    Mod Rheumatol 30(5):884-893,2020
    
    
15. Matsumoto I, Kurata I, Ohyama A, Kawaguchi H, Ebe H, Osada A, Kondo Y, Tsuboi H, Sumida T.:
    Revisit of autoimmunity to glucose-6-phosphate isomerase in experimental and rheumatoid arthritis.
    Mod Rheumatol 30(2):232-238,2020
    
    
16. Tsuboi H, Honda F, Takahashi H, Ono Y, Abe S, Kondo Y, Matsumoto I, Sumida T.:
    Pathogenesis of IgG4-related disease. Comparison with Sjogren's syndrome.
    Mod Rheumatol 30(1):7-16,2020
    
    
17. Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H.:
    Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD.
    Mod Rheumatol 30(3):551-557,2020
    
    
18. Hagiwara S, Tsuboi H, Terasaki T, Terasaki M, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
    Association of anti-cyclic citrullinated peptide antibody with clinical features in patients with psoriatic arthritis.
    Mod Rheumatol 30(2):365-372,2020
    
    
19. Furukawa H, Oka S, Kawasaki A, Hidaka M, Shimada K, Kondo Y, Ihata A, Matsushita T, Matsumoto T, Hashimoto A, Matsumoto I, Komiya A, Kobayashi K, Osada A, Katayama M, Okamoto A, Setoguchi K, Kono H, Hamaguchi Y, Matsui T, Fukui N, Tamura H, Takehara K, Nagaoka S, Sugii S, Sumida T, Tsuchiya N, Tohma S.:
    Human Leukocyte Antigen in Japanese patients with idiopathic inflammatory myopathy.
    Mod Rheumatol 30(4):696-702,2020
    
    
20. Tsuboi H, Iizuka-Koga M, Asashima H, Takahashi H, Kudo H, Ono Y, Honda F, Iizuka A, Segawa S, Abe S, Yagishita M, Yokosawa M, Kondo Y, Moriyama M, Matsumoto I, Nakaramura S, Sumida T.:
    Up-regulation and pathogenic roles of CCL18-CCR8 axis in IgG4-related disease.
    Mod Rheumatol 30(4):729-737,2020
    
    
21. Shimizu M, Asashima H, Terasaki M, Toko H, Honda F, Ohyama A, Yagishita M, Takahashi H, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
    Renal Sarcoidosis With Multiple Organ Involvement.
    J Clin Rheumatol 26(3):e55,2020
    
    2019
    

1. Yokoyama N, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Hirano F, Sada K-e, Matsumoto I, Kusaoi M, Amano H, Nagaoka S, Setoguchi K, Nagai T, Shimada K, Sugii S, Hashimoto A, Matsui T, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Migita K, Kono H, Hasegawa M, Kobayashi S, Yamada H, Nagasaka K, Sugihara T, Yamagata K, Ozaki S, Tamura N, Takasaki Y, Hashimoto H, Makino H, Arimura Y, Harigai M, Sato S, Sumida T, Tohma S, Takehara K, Tsuchiya N.:
   Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis, but not with ANCA-associated vasculitis in a Japanese population.
   Sci Rep 9(1):16366,2019
   
   
2. Kurata I, Matsumoto I, Ohyama A, Osada A, Ebe H, Kawaguchi H, Kaneko S, Kondo Y, Tsuboi H, Tomioka A, Kaji H, Sumida T.:
   Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis..
   Ann Rheum Dis 78(11):1488-1496,2019
   
   
3. Namba N, Kawasaki A, Sada K, Hirano F, Kobayashi S, Yamada H, Furukawa H, Shimada K, Hashimoto A, Matsui T, Ngasaka K, Sugihara T, Suzuki A, Yamagata K, Sumida T, Tohma S, Homma S, Ozaki S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N, On behalf of Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS):
   Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.
   Ann Rheum Dis 78(8):1144-1146,2019
   
   
4. Takamuki R, Okiyama N, Inoue S, Endo R, Saito A, Nakamura Y, Ishitsuka Y, Watanabe R, Fujisawa Y, Kondo Y, Chino Y, Sumida T, Fujimoto M.:
   Successful treatment of refractory cutaneous lupus vasculitis with i.v. immunoglobulin.
   J Dermatol 46(7):e253-e255,2019
   
   
5. Akizuki S, Ishigaki K, Kochi Y, Law S-M, Matsuo K, Ohmura K, Suzuki A, Nakayama M, Iizuka Y, Koseki H, Ohara O, Hirata J, Kamatani Y, Matsuda F, Sumida T, Yamamoto K, Okada Y, Mimori T, Terao C.:
   PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune-phenotypes.
   Ann Rheum Dis 78(4):509-51,2019
   
   
6. Kurata I, Tsuboi H, Terasaki M, Shimizu M, Toko H, Honda F, Ohyama A, Yagishita M, Osada A, Kaneko S, Ebe H, Kawaguchi H, Takahashi H, Hagiwara S, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
   Effect of biological disease modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis.
   Intern Med 58(12):1703-1712,2019
   
   
7. Kawaguchi H, Matsumoto I, Osada A, Kurata I, Ebe H, Tanaka Y, Inoue A, Umeda N, Kondo Y, Tsuboi H, Ishigami A, Sumida T.:
   Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
   Mod Rheumatol 29(6):964-969,2019
   
   
8. Ebe H, Matsumoto I, Osada A, Kurata I, Kawaguchi H, Kondo Y, Tsuboi H, Sumida T.:
   Splice variant of STEAP4 localizes in the nucleus, making it a possible transcriptional regulator of IL-6 production.
   Mod Rheumatol 29(4):714-716,2019
   
   
9. Kohsaka H, Mimori T, Kanda T, Shimizu J, Sunada Y, Fujimoto M, Kawaguchi Y, Jinnin M, Muro Y, Ishihara S, Tomimitsu H, Sumida T.:
   Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists, and dermatologists in Japan.
   Mod Rheumatol 29(1):1-19,2019
   
   
10. Ohyama A, Tsuboi H, Noma H, Terasaki M, Shimizu M, Toko H, Honda F, Yagishita M, Takahashi H, Asasahima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
    Associations between maternal clinical features and fetal outcomes in pregnancies of mothers with connective tissue diseases.
    Mod Rheumatol 29(2):344-350,2019
    
    
11. Honda F, Tsuboi H, Toko H, Terasaki T, Terasaki M, Shimizu M, Ohyama A, Yagishita M, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.
    Contrast enhanced computed tomography revealed gallbladder hemorrhage due to active vasculitis in a patient with microscopic polyangiitis.
    J Clin Rheumatol 25(6):e84-e85,2019
    
    

2018年

1. Segawa S, Kondo Y, Nakai Y, Iizuka A, Kaneko S, Yokosawa M, Furuyama K, Tsuboi H, Goto D, Matsumoto I, Sumida T.:
   Placenta specific-8 suppresses IL-18 production through regulation of autophagy and is associated with Adult Still disease.
   J Immunol 201(12):3535-3545,2018
   
   
2. Iizuka A, Segawa S, Kondo Y, Kaneko S, Yokosawa M, Furuyama K, Miki H, Tahara-Hanaoka S, Shibuya A, Tsuboi H, Goto D, Matsumoto I, Shibayama S, Sumida T.:
   Allergy inhibitory receptor-1 inhibits autoantibody production via upregulation of apoptotic debris clearance by macrophages.
   Int J Rheum Dis 21(12):2071-2078,2018
   
   
3. Nakamagoe K, Yanagiha H, Miyake Z, Kondo Y, Hiyama T, Ishii A, Kaji Y, Oshika T, Sumida T, Tamaoka A.
   Monocular Oculomotor Nerve Disorder Manifesting as Cranial Neuropathy in Systemic Lupus Erythematosus: A Case Report.
   Intern Med 57(23):3445-3449,2018
   
   
4. Shiraishi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazawaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T.:
   Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study.
   Sci Rep 8(1):10262,2018
   
   
5. Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Funakubo-Asanuma Y, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T.:
   Evidence-based clinical practice guideline for adult Still's disease.
   Mod Rheumatol 28(5):736-757,2018
   
   
6. Kawaguchi H, Matsumoto I, Osasda A, Kurata I, Ebe H, Tanaka Y, Inoue A, Umeda N, Kondo Y, Tsuboi H, Shinkai Y, Kumagai Y, Ishigami A, Sumida T.:
   Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
   Arthritis Res Ther 20(1):66,2018
   
   
7. Toko H, Tsuboi H, Umeda N, Honda F, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
   Intractable Hemophagocytic Syndrome Associated with Systemic Lupus Erythematosus Resistant to Corticosteroids and Intravenous Cyclophosphamide That Was Successfully Treated with Cyclosporine A.
   Intern Med 57(18):2747-2752,2018
   
   
8. Sumida T, Azuma N, Moriyama M, Takahashi H, Asashima H, Honda F, Abe S, Ono Y, Hirota T, Hirata S, Tanaka Y, Shimizu T, Nakamura H, Kawakami A, Sano H, Ogawa Y, Tsubota K, Ryo K, Saito I,Tanaka A, Nakamura S, Takamura E, Tanaka M, Suzuki K, Takeuchi T, Yamakawa N, Mimori T, Ohta A, Nshiyama,S Yoshihara T, Suzuki Y, Kawano M, Tomiita M, Tsuboi H.:
   Clinical practice guideline for Sjogren's syndrome 2017.
   Mod Rheumatol 28(3):383-408,2018
   
   
9. Takahashi H, Tsuboi H, Umeda N, Toko H, Honda F, Ohyama A, Abe S, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Hirose Y, Hara A, Sumida T.:
   A case of otitis media with ANCA-associated vasculitis accompanied with pituitary mass successfully treated by corticosteroids.
   Modern Rheumatol Case Reports 2(2)185-190,2018
   
   
10. Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovsk? J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.:
    Splicing variant of WDFY4 augments MDA5 signaling and the risk of clinically amyopathic dermatomyositis.
    Ann Rheum Dis 77(4):602-611,2018
    
    
11. Kaneko S, Kondo Y, Yokosawa M, Furuyama K, Segawa S, Tsuboi H, Kanamori A, Matsumoto I, Yamazaki M, Sumida T.:
    The RORgt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients.
    Mod Rheumatol 28(5):814-825,2018
    
    
12. Yagishita M, Kondo Y, Terasaki T, Terasaki M, Shimizu M, Honda F, Oyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.
    A case of clinically amyopathic dermatomyositis with interstitial pneumonia successfully treated with plasma exchange.
    Intern Med 57(13):1935-1938,2018
    
    
13. Kondo Y, Yokosawa M, Kaneko S, Furuyama K, Segawa S, Tsuboi H, Matsumoto I, Sumida T.
    Transcriptional regulation of CD4+ T cell differentiation in experimentally-induced arthritis and rheumatoid arthritis.
    Arthritis Rheum 70(5):653-661,2018
    
    
14. Ebe H, Matsumoto I, Kawaguchi H, Kurata I, Tanaka Y, Inoue A, Kondo Y, Tsuboi H, Sumida T.
    Clinical and functional significance of STEAP4-splice variant in CD14⁺ monocytes in patients with rheumatoid arthritis.
    Clin Exp Immunol 191(3):338-348,2018
    
    
15. Fujita-Tanaka H, Ogawa Y, Muro Y, Ogawa-Momohara M, Asashima H, Tsuboi H, Sumida T, Akiyama M.
    Pansclerotic morphea associated with hypohidrosis and anti-M3 muscarinic acetylcholine receptor antibodies.
    Br J Dermatol 178(3):e210-e211,2018
    
    
16. Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mirori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T.
    Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
    Mod Rheumatol 28(4):642-648,2018
    
    
17. Kawasaki A, Yamashita K, Hirano F, Sada KE, Tsukui D, Kondo Y, Kimura Y, Asako K, Kobayashi S, Yamada H, FurukawaH, Nagasaka K, Sugihara T, Yamagata K, Sumida T, Tohma S, Kono H, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.
    Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.
    J Hum Genet 63(1):55-62,2018
    
    
18. Kawaguchi H, Tsuboi H, Yagishita M, Terasaki T, Terasaki M, Shimizu M, Honda F, Ohyama A, Takahashi H, Miki H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
    A Case of Severe Adult-onset Still Disease with Constrictive pericarditis and Pleuritis that Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A.
    Intern Med 57(7):1033-1038,2018
    
    
19. Takahashi H, Tsuboi H, Yokosawa M, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
    Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjogren's syndrome associated with rheumatoid arthritis: Utility to evaluate and predict response to treatment.
    Mod Rheumatol 28(2):300-307,2018
    
    

2017年

1. Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
   Recurrent Kikuchi-Fujimoto Disease Successfully Treated by the Concomitant Use of Hydroxychloroquine and Corticosteroids.
   Intern Med 56(24):3373-3377,2017
   
   
2. Takahashi H, Tsuboi H, Asashima H, Hirota T, Kondo Y, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
   cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
   Clin Exp Immunol 190(1):96-109,2017
   
   
3. Nitta T, Kochi Y, Muro R, Tomofuji Y, Okamura T, Murata S, Suzuki H, Sumida T, Yamamoto K, Takayanagi H.:
   Human thymoproteasome variations impact CD8 T cell selection and autoimmunity.
   Science Immunol 2(12):eaan5165,2017
   
   
4. Iizuka-Koga M, Asashima H, Ando M, Lai C-Y, Mochizuki S, Nakanishi M, Nishimura T, Tsuboi H, Hirota T, Takahashi H, Masumoto I, Otsu M, Sumida T.:
   Functional analysis of dendritic cells generated from T-iPS cells from CD4+ T cell clones of Sjogren's syndrome.
   Stem Cell Reports 8(5):1155-1163,2017
   
   
5. Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
   Comparison of the performance of new ACR-EULAR classification criteria for primary Sjogren's syndrome with former sets of criteria in Japanese patients.
   Ann Rheum Dis 76(12):1980-1985,2017
   
   
6. Furukawa S, Moriyama N, Miyake K, Nakashima H, Tanaka A, Maehara T, Iizuka-Koga M, Tsuboi H, Hayashida JN, Ishiguro N, Yamauchi M, Sumida T, Nakamura S. :
   Interleukin-33 produced by M2 macrophages and other immune cells contributes to immune reaction of IgG4-related disease.
   Sci Rep 7:42413,2017
   
   
7. Abe S, Tsuboi H, Toko H, Honda F, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sakai S, Aonuma K, Sumida T.:
   The effectiveness of upfront pulmonary vasodilators combination therapy in addition to corticosteroids for pulmonary arterial hypertension associated with systemic lupus erythematosus: two successful cases utilizing both corticosteroids and an upfront combination of vasodilators.
   Modern Rheumatol Case Reports 1(2):73-78,2017
   
   
8. Umeda N, Matsumoto I, Tanaka Y, Kawaguchi H, Ebe H, Kagami Y, Ishigami A, Sumida T.:
   Anti-cyclic citrullinated glucose-6-phosphate isomerase peptide -7 (CCG-7) antibodies were suppressed by biologics treatment and deposited to citrullinated proteins in CD68-positive cells in the RA synovium.
   Mod Rheumatol 27(5):914-916,2017
   
   
9. Yokosawa M, Kondo Y, Tahara M, Iizuka M, Segawa S, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
   T-bet overexpression regulates AHR-mediated Th-17 differentiation through an IFN??-independent pathway.
   Clin Exp Immunol 188(1):22-35,2017
   
   
10. Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami HI, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T.:
    A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.
    Mod Rheumatol 27(5):849-854,2017
    
    
11. Tahara M, Tsuboi H, Segawa S, Asashima H, Iizuka M, Hirota T, Takahashi H, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
    RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sj?gren's syndrome-like sialadenitis.
    Clin Exp Immunol 187(2):213-224,2017
    
    
12. Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, Kondo Y, Ohta M, Wakasa Y, Matsumoto I, Takaiwa F, Sumida T.:
    Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of glucose-6-phosphate-isomerase.
    Mod Rheumatol 27(3):457-465,2017
    
    
13. Ishiguro N, Atsumi T, Harigai M, Mimori T, Nishimoto N, Sumida T, Takeuchi T, Tanaka Y, Nakasone A, Takagi N, Yamanaka H.:
    Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
    Mod Rheumatol 27(2):217-226,2017
    
    
14. Hamaguchi Y, Sumida T, Kawaguchi Y, Ihn H, Tanaka S, Asano Y, Motegi SI, Kuwana M, Endo H, Takehara K.:
    Safety and tolerability of bosentan for digital ulcers in Japanese patients with
    systemic sclerosis: Prospective, multicenter, open-label study.
    J Dermatol 44(1):13-17,2017
    
    

2016年

1. Lin SY, Matsuno Y, Yokosawa M, Suzuki T, Morishima Y, Sakamoto T, Sumida T, Hizawa N.
   Analysis of scrub typhus involvement of the lung by bronchoalbeolar lavage: A case report.
   Respir Investig 54(6):487-489,2016
   
   
2. Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Yagishita M, Takahashi H, Kurata I, Ohyama A, Honda F, Asashima H, Miki H, Umeda N, Kondo Y, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
   Effectiveness of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy) trial.
   Mod Rheumatol 26(6):891-899,2016
   
   
3. Hagiwara S, Tsuboi H, Honda F, Takahashi H, Kurata I, Ohyama A, Yagishita M, Abe S, Kurashima Y, Kaneko S, Kawaguchi H, Takahashi H, Ebe H, Yokosawa M, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
   Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis.
   Mod Rheumatol 26(6):857-862,2016
   
   
4. Inoue A, Matsumoto I, Tanaka Y, Umeda N, Takai C, Kawaguchi H, Ebe H, Yoshida H, Matsumoto Y, Segawa S, Takahashi S, Sumida T.:
   TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.
   Sci Rep 6:38684, 2016
   
   
5. Hachiya Y, Kawasaki A, Oka S, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Setoguchi K, Nagai T, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Kono H, Hirohata S, Takasaki Y, Hashimoto H, Sumida T, Nagaoka S, Tohma S, Furukawa H, Tsuchiya N.:
   Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: a Case-control Association Study.
   PLoS One 11(6):e0158065,2016
   
   
6. Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, Yamada H, Furukawa H, Yamagata K, Sumida T, Miyasaka N, Tohma S, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.:
   Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
   PLoS One 11(5):e0154393,2016
   
   
7. Furukawa H, Oka S, Kawasak A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N. :
   Human leukocyte antigen and systemic sclerosis in Japanese: The sign of the four independent protective alleles, DRB1*13:02, DRB1*14:06,　DQB1*03:01, and DPB1*02:01.
   PLoS One 11(4):e0154255,2016
   
   
8. Segawa S, Goto D, Iizuka A, Kaneko S, Yokosawa M, Kondo Y, Matsumoto I, Sumida T.:
   The regulatory role of IFN-g producing gammadelta T cells via the suppression of Th17 cell activity in bleomycin-induced pulmonary fibrosis.
   Clin Exp Immunol 185(3):348-60,2016
   
   
9. Ohta M, Moriyama M, Maehara T, Gion Y, Furukawa S, Tanaka A, Hayashida J, Yamauchi M, Ishiguro N, Miakami Y, Tsuboi H, Iizuka-Koga M, Kawano S, Sato Y, Kiyoshima T, Sumida T, Nakamura S.:
   DNA microarray analysis of submandibular glands in IgG4-related disease indicates a role for MARCO and other innate immune related proteins.
   Medicine 95(7):e2853,2016
   
   
10. Celi Sun C, Molineros J, Looger L, Kim K, Zhou XJ, Kim-Howard X, Motghore P, Bhattarai K, Adler A, So-Young Bang SY, Lee HS, Kim TH, Kang YM, Suh CH, Chung WT, Park YB, Choe JY, Shim SC, Lee SS, Han BG, Dozmorov M, Wren J, Harley J, Chua KH, Zhang H, Bae SC, Jin Kim YJ , Okada Y, Kochi Y, Suzuki A, Kubo M, Sumida T, Yamamoto K, Shen N, Ma J, Qi YY, Kaufman K.:
    High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry.
    Nat Genet 48(3):323-30,2016
    
    
11. Nakahashi-Oda C, Udayanga KGS, Nakamura Y, Nakazawa Y, Totsuka N, Miki H, Iino S, Tahara-Hanaoka S, Honda S, Shibuya K, Shibuya A：
    Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces.
    Nature Immunol 17(4):441-50,2016
    
    
12. Miki H, Tsuboi H, Kaneko S, Takahashi H, Yokosawa M, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Nishimura B, Sugano M, Matsumoto I, Sumida T.:
    A case of refractory Kimura disease with a buccal bulky mass successfully treated with
    low-dose cyclosporine A: report and review of the literature.
    Allergol Int 65(2):212-4,2016
    
    
13. Tsuboi H, Sumida T, Noma H, Yamagishi K, Anami A, Fukushima K, Horigome H, Maeno Y, Kishimoto M, Takasaki Y, Nakayama M, Waguri M, Sago H, Murashima A.:
    Maternal predictive factors for fetal congenital heart block in pregnant mothers positive
    for anti-SS-A antibodies.
    Mod Rheumatol 26(4):569-75,2016
    
    
14. Umeda N, Matsumoto I, Kawaguchi H, Kurashima Y, Kondo Y, Tsuboi H, Ogishima H, Suzuki T, Kagami Y, Sakyu T, Ishigami A, Maruyama N, Sumida T.:
    Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
    Clin Rheumatol 35(5):1181-8,2016
    
    
15. Ikeda K, Narita A, Ogasawara M, Ohno S, Kawahito Y, Kawakami A, Ito H, Matsushita I, Suzuki T, Misaki K, Ogura T, Kamishima T, Seto Y, Nakahara R, Kaneko A, Nakamura T, Henmi M, Fukae J, Nishida K, Sumida T, Koike T.:
    Consensus-based identification of factors related to false-positives in ultrasound scanning of synovitis and tenosynovitis.
    Mod Rheumatol 26(1):9-14,2016
    
    
16. Hirota T, Suzuki T, Ogishima H, Hagiwara S, Ebe H, Takahashi H, Yokosawa M, Umeda N, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
    Evaluation of changes in magnetic resonance images following 24 and 52 weeks treatment of rheumatoid arthritis with infliximab, tocilizumab or abatacept.
    Mod Rheumatol 26(1):29-35,2016
    
    
17. Tanaka Y, Takeuchi T, Miyasaka N, Sumida T, Mimori T, Koike T, Endo K, Mashino N, Yamamoto K.:
    Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus including lupus nephritis who are refractory to conventional therapy.
    Mod Rheumatol 26(1):80-6,2016
    
    
18. Seror R, Bootsma H, Saraux A, Bowman S J, Theander E, Brun J G, Baron G, Leguern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dorner T, Tzioufas A, Gottenberg J-E, Laque R S, Mandl T, Hachulla E, Sivils K L, Ng W-F, Fauchais A-L, Bombardieri S, Valesini G, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize A A, Vollenveider C, Ravaud P, Meiners P, Brito-Zeron P, Vitali C, Mariette X.:
    Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
    Ann Rheum Dis 75(2)382-389,2016
    
    

2015年

1. Kato M, Chino Y, Sato R, Kinoshita K, Tsuji H, Tokuda Y, Tamaoka A, Sumida T.:
   Lateral medullary infarction in a patient with central nervous system lupus.
   Int J Rheum Dis 18(1):108-10,2015
   
   
2. Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, Fujio K, Yamamoto K.:
   Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.
   Sci Rep 21;5:13041,2015
   
   
3. Takahashi H, Tsuboi H, Abe S, Yokosawa M, Hagiwara S, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
   Magnetic resonance imaging can reveal fascial vasculitis in a patient with microscopic polyangiitis.
   Scand J Rheumatol 44(6):511-3,2015
   
   
4. Murayama MA, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, Tateishi K, Ishigame H, Yabe R, Ikeda S, Seno A, Chi HH, Hashiguchi Y, Kurata R, Tada T, Kubo S, Sato N, Liu Y, Hattori M, Saijo S, Matsushita M, Fujita T, Sumida T, Iwakura Y.:
   CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis.
   Nat Commun 25;6:8483,2015
   
   
5. Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K, Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.:
   Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
   PLoS One 10(5):e0126582,2015
   
   
6. Ogata A, Atusmi T, Fukada T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, MSc, and the MUSASHI Study Investigators:
   Results of switching from intravenous to subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis: Extension of the MUSASHI study.
   Arthritis Care Res 67(10):1354-62,2015
   
   
7. Yoon JH, Sudo K, Kuroda M, Kato M, Lee I, Nakae S, Imamura T, Kim J, Ju JH, Matsuzaki K, Matsumoto I, Sumida T, Mamura M.:
   Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation.
   Nat Commun 21;6:7600,2015
   
   
8. Asashima H, Tsuboi H, Iizuka M, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
   The Anergy Induction of M3 Muscarinic Acetylcholine Receptor-Reactive CD4+ T Cells Suppresses Experimental Sialadenitis-like Sjogren's Syndrome.
   Arthritis Rheum 67(8):2213-25,2015
   
   
9. Miki H, Nakahashi-Oda C, Sumida T, Sibuya A.:
   Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant-Induced Th2 Responses.
   J Immunol 194(11):5069-76,2015
   
   
10. Kondo Y, Yao Z, Tahara M, Izuka M, Yokosawa M, Kaneko S, Segawa S, Tsuboi H, Yoh K, Takahashi S, Matsumo I, Sumida T.:
    Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice.
    Arthritis Res Ther 17(1):105,2015
    
    
11. Takai C, Matsumoto I, Inoue A, Umeda N, Tanaka Y, Kurashima Y, Wada Y, Narita I, Sumida T.:
    Specific overexpression of TNFAIP9 in CD14+CD16- monocytes in patients
    with rheumatoid arthritis- Comparative analysis with TNFAIP3.
    Clin Exp Immunol 180(3):458-66,2015
    
    
12. Kurata I, Tsuboi H, Takahashi H, Yagishita M, Abe S, Ebe H, Takahashi H, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
    A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus
    successfully treated by corticosteroid and methotrexate.
    Rheumatology (Oxford) 54(7):1160,2015
    
    
13. Takahashi H, Tsuboi H, Ogishima H, Yokosawa M, Takahashi H, Yagishita M, Abe S, Hagiwara S, Asashima H, Umeda N, Kondo Y, Suzuki T, Matsumoto I, Sumida T.:
    [18F]fluorodeoxyglucose positron emission tomography/computed tomography can reveal subclinical prostatitis in a patient with IgG4-related disease.
    Rheumatology (Oxford) 54(6):1113,2015
    
    
14. Kurata I, Tsuboi H, Takahashi H, Inoue S, Ebe H, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Hoshi S, Oshika T, Sumida T.:
    Successful treatment with infliximab for refractory uveitis in a patient with Behcet's disease on hemodialysis and a review of literature for infliximab use on hemodialysis.
    Intern Med 54(12):1553-7,2015
    
    
15. Iizuka M, Tsuboi H, Matsuo N, Asashima H, Hirota T, Kondo Y, Iwakura Y, Takahashi S, Matsumoto I, Sumida T.:
    A crucial role of RORgt in the development of spontaneous sialadenitis-like Sjogren's syndrome.
    J Immunol 194(1):56-67,2015
    
    
16. Furukawa S, Moriyama M, Tanaka A, Maehara T, Tsuboi H, Iizuka M, Hayashida J, Ohta M, Saeki T, Notohara K, Sumida T, Nakamura S.:
    Polarized M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.
    Clin Immunol 156(1):9-18,2015
    
    
17. Takahashi H, Yamashita H, Kubota K, Miyata Y, Okasaki M, Morooka M, Takahashi Y, Kaneko H, Kano T, Mimori A:
    Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica.
    Mod Rheumatol 25(4):546-51,2015
    
    
18. Takahashi H, Tsuboi H, Kurata I, Takahashi H, Inoue S, Ebe H, Yokosawa M, Hagiwara S, Hirota T, Asashima H, Kaneko S, Kawaguchi H, Kurashima Y, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
    Predictors of the response to treatment in acute lupus 1 hemophagocytic syndrome.
    Lupus 24(7):659-68,2015
    
    
19. Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, Sumida T.:
    Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan.
    Mod Rheumatol 25(3):393-400,2015
    
    
20. Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Satoru T, Sibayama S, Matsumoto I, Sumida T. :
    T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice..
    Clin Exp Immunol 179(2):197-209,2015
    
    
21. Yokosawa M, Tsuboi H, Nasu K, Hagiya C, Hagiwara S, Hirota T, Ebe H, Takahashi H, Asashima H, Kondo Y, Ogishima H, Suzuki T, Minami M, Bukawa H, Matsumoto I, Sumida T.:
    Usefulness of MR imaging of the parotid glands in patients with secondary Sjogren’s syndrome associated with rheumatoid arthritis.
    Mod Rheumatol 25(3):415-20,2015
    
    
22. Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Hagiya C, Asashima H, Takai C, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
    Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy) trial. An open label, one-year, prospective study. Interim analysis of 32 patients for 24 weeks.
    Mod Rheumatol 25(2):187-93,2015
    
    
23. Suzuki T, Hirota T, Ogishima H. Umeda N, Kondo Y, Yokosawa M, Miki H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
    Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for two years.
    Int J Rheum Dis 18(1):108-10,2015
    
    
24. Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Doner T, Bootsma H, Tzioufas A, Solans-Laque R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Valesini G, Bartoloni E, Saraux A, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ; EULAR Sjoren's Task Force.:
    Validation of EULAR primary Sjogren's Syndrome disease activity and patient indexes.
    Ann Rheum Dis 74(5):859-66,2015
    
    
25. Gazal S, Sacre K, Allanore Y, Teruel M, Goodall AH, Tohma S, Alfredsson L, Okada Y, Xie G, Constantin A, Balsa A, Kawasaki A, Nicaise P, Amos C, Rodriguez-Rodriguez L, Chioccia G, Boileau C, Zhang J, Vittecoq O, Barnetche T, Gonzalez-Gay MA, Furukawa H, Cantagrel A, Le Loet X, Sumida T, Hurtado-Nedelec M, Richez C, Chollet-Martin S, Schaeverbeke T, Combe B, Khoryati L, Coustet B, El-Benna J, Siminovitch K, Plenge R, Padyukov L, Martin J, Tsuchiya N, Dieud P.:
    Identification of Secreted Phosphoprotein 1 Gene as a new Rheumatoid Arthritis Susceptibility Gene.
    Ann Rheum Dis 74(3):e19,2015
    
    
26. Iizuka M, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
    M3 muscarinic acetylcholine receptor reactive IL-17- producing T cells promotes development of Sjogren's syndrome like sialadenitis.
    Mod Rheumatol 25(1):158-60, 2015
    
    
27. Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, Takai C, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida T.:
    Clinical features of patients with IgG4-related disease complicated with
    perivascular lesions.
    Mod Rheumatol 25(1):105-9,2015
    
    
    

2014年

1. Kawasaki A, Furukawa H, Nishida N, Warabi E, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Nagaoka S, Setoguchi K, Nagai T, Hirohata S, Shimada K, Sugai S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Okamoto A, Kono H, Tokunaga K, Takasaki Y, Hashimoto H, Sumida T, Tohma S, Tsuchiya N.:
   Association of Functional Polymorphisms in Interferon Regulatory Factor 2 (IRF2) with Susceptibility to Systemic Lupus Erythematosus: a Case-Control Association Study.
   PLoS One 9(10):e109764,2014
   
   
2. Terao C, Yamada R, Mimori T, Yamamoto K, Sumida T.;
   A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex.
   Lupus 23(13):1435-42,2014
   
   
3. Tanaka K, Shiota j, Mikami M, Inoue Y, Sumida T, Matsumoto I, Muramoto K.:
   The combined effects of iguratimod with anti-TNFα antibody on experimental arthritis models in mice.
   Inflamm Regen 34(3):157-164,2014
   
   
4. Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Takaiwa F, Sumida T.:
   Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
   Plant Biotechnol J 12(8):1143-53,2014
   
   
5. Tsuboi H, Nakai Y, Iizuka M, Asashima H, Hagiya C, Tsuzuki S, Hirota T, Miki H, Hagiwara S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Yoshihara T, Abe K, Sumida T.:
   DNA microarray analysis of labial salivary glands in IgG4-related disease. Comparison with Sjogren's syndrome.
   Arthritis Rheum 66(10):2892-9,2014
   
   
6. Hirota T, Suzuki T, Hagiwara S, Ogishima H, Matsumoto I, Sumida T.:
   Analysis of the usefulness of magnetic resonance imaging evaluation for rheumatoid arthritis treated with biological agents in the early phase: Retrospective observation of abatacept and infliximab.
   Clin Exp Rheumatol 32(6):991,2014
   
   
7. Sakai R, Cho SK, Nanki T, Koike R, Watanabe K, Yamazaki H, Nagasawa H, Amano K, Tanaka Y, Sumida T, Ihata A, Yasuda S, Nakajima A, Sugihara T, Tamura N, Fujii T, Dobashi H, Miura Y, Miyasaka N, Harigai M, the REAL study group:
   The risk of serious infection in patients with rheumatoidarthritis treated with tumor necrosis factor inhibitorsdecreasedovertime: a report from the registry of Japanese rheumatoid arthritis patientsfor long-term safety (REAL) database.
   Rheumatol Int 34(12):1729-36,2014
   
   
8. Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T, Takaiwa F.:
   Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis.
   Biosci Biotech Bioch 78(10):1662-8,2014
   
   
9. Tsuboi H, Ohira H, Asashima H, Tsuzuki S, Iizuka M, Matsuo N, Kondo Y, Matsumoto I, Sumida T.:
   Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis.
   Hepatol Res 44(14):E471-9,2014
   
   
10. Tanaka Y, Matsumoto I, Inoue A, Umeda N, Takai C, Sumida T.:
    Antigen-specific overexpression of human cartilage glycoprotein 39 on CD4+CD25+Foxp3+ Treg cells in the generation of glucose-6-phosphate isomerase induced arthritis.
    Clin Exp Immunol 177(2):419-27,2014
    
    
11. Matsumoto I, Inoue A, Takai C, Umeda N, Tanaka Y, Kurashima Y, Sumida T. :
    Regulatory roles of tumor necrosis factor alpha-induced proteins (TNFAIP) 3 and 9 in arthritis.
    Clin Immunol 153(1):73-8,2014
    
    
12. Segawa S, Goto D, Horikoshi M, Kondo Y, Umeda N, Hagiwara S, Yokosawa M, Hirota T, Miki H, Tsuboi H, Ogishima H, Suzuki T, Matsumoto I, Sumida T.：
    Involvement of CD161+Vδ1+γδT cells in systemic sclerosis: Association with interstitial pneumonia.
    Rheumatology(Oxford) 53(12):2259-69,2014
    
    
13. Hagiwara S, Tsuboi H, Hagiya C, Yokosawa M, Hirota T, Ebe H, Takahashi H, Ogishima H, Asashima H, Kondo Y, Umeda N, Suzuki T, Hitomi S, Matsumoto I, Sumida T.:
    Pulmonary nocardiosis in patients with connective tissue disease: A report of two cases.
    Intractable Rare Dis Res 3(1):25-28,2014
    
    
14. Sumida T, Tsuboi H, Asashima H, Iizuka M, Matsumoto I.:
    Highlights from the 12th International Symposium on Sjogren's Syndrome in Kyoto, Japan.
    Sjogren's Quarterly 9(1):8-14,2014
    
    
15. Takahashi H, Yamashita H, Morooka M, Kubota K, Takahashi Y, Kaneko H, Kano T, Mimori A.:
    The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
    Joint Bone Spine 81(4):331-6,2014
    
    
16. Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Amano H, Nagai T, Hirohara S, Setoguchi K, Kono Hm Okamoto A, Chiba N, Suematsu E, Katayama M, Migita K, Suda A, Ohno S, Hashimoto H, Takasaki Y, Sumida T, Nagaoka S, Tsuchiya N, Tohma S.:
    Human Leukocyte Antigens and Systemic Lupus Erythematosus: A Protective Role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
    PLoS One 9(2):e87792,2014
    
    
17. Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I. :
    The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: A Critical Review
    J Autoimmunity 51:44-50,2014
    
    
18. Hara M, Ishiguro N, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Yamamoto K; Iguratimod-Clinical Study Group.:
    Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial.
    Mod Rheumatol 24(3):410-8,2014
    
    
19. Ikeda K, Seto Y, Natita A, Kawakami A, Kawahito Y, Ito H, Matsushita I, Ohno S, Nishida K, Suzuki T, Kaneko A, Ogasawara M, Fukae J, Henmi M, Sumida T, Kamishima T, Koike T, JCR-CoSMUS :
    Ultrasound assessment of synovial pathologies in rheumatoid arthritis using comprehensive multi-plane images of the 2nd metacarpophalangeal joint.
    Arthritis Rheum 66(3):523-32,2014
    
    
20. Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T.:
    Primary and secondary surveys on epidemiology of Sjogren's syndrome in Japan.
    Mod Rheumatol 24(3):464-70,2014
    
    
21. Hagiya C, Tsuboi H, Yokosawa M, Hagiwara S, Takai C, Hirota T, Asashima H, Miki H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Ogishima H, Suzuki T, Hiraoka T, Kaji Y, Matsumoto I, Ohshika T, Sumida T.:
    Clinicopathological features of IgG4-related disease complicated with orbital involvement.
    Mod Rheumatol 24(3):471-6,2014
    
    
22. Ogishima H, Tsuboi H, Naoto Umeda, Horikoshi M, Kondo Y, Sugihara M, Suzuki T, Matsumoto I, Sumida T:
    Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis.
    Mod Rheumatol 24(1):60-68,2014
    
    
23. Ito S, Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, Goto D, Matsumoto I, Sumida T:
    Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
    Mod Rheumatol 21(1):52-59,2014
    
    
24. Kaneko S, Yamashita H, Sugimori Y, Takahashi Y, Kaneko H, Kano T, Mimori A.:
    Rheumatoid arthritis-associated aortitis: a case report and literature review.
    Springerplus 9;3:509,2014
    

2013年

1. Yoon JH, Jung SM, Park SH, Kato M, Yamashita T, Lee IK, Sudo K, Nakae S, Han JS, Kim OH, Oh BC, Sumida T, Kuroda M, Ju JH, Jung KC, Park SH, Kim DK, Mamura M.:
   Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing Eomesodermin in cytotoxic T lymphocytes.
   EMBO Mol Med 5(11):1720-39,2013
   
   
2. Kawasaki A, Inoue N, Ajimi C, Sada K, Kobayashi S, Yamada H, Furukawa H, Sumida T, Tohma S, Miyasaka N, Matsuo S, Ozaki S, Hashimoto H, Makino H, Harigai M, Tsuchiya N.:
   Association of IRF5 polymorphism with MPO-ANCA positive vasculitis in a Japanese population.
   Genes Immun 14(8):527-9,2013
   
   
3. Furukawa H, Kawasaki A, Oka S, Shimada K, Masui T, Ikenaka T, Hashimoto A, Okazaki Y, Takaoka H, Futami H, Komiya A, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Nagai T, Hirohata S, Setoguchi K, Suda A, Nagaoka S, Kono H, Okamoto A, Chiba N, Suematsu E, Fukui N, Hashomoto H, Sumida T, Ono M, Tsuchiya N, Tohma S:
   Association of a Single Nucleotide Polymorphism in the SH2D1A Intronic Region with Systemic Lupus Erythematosus.
   Lupus 22(5):497-503,2013
   
   
4. Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tanaka Y, Tsuboi H, Suzuki T, Hayashi T, Ito S, Tsuchiya N, Sumida T:
   Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
   Clin Exp Immunol 172(1):44-53,2013
   
   
5. Shimane K, Kochi Y, Suzuki A, Okada Y, Tomonori I, Horita T, Saito K, Okamoto A, Nishimoto N, Myouzen K, Hirakata M, Sumida T, Takasaki Y, Yamada R, Kamatani N, Nakamura Y, Kubo M, Yamamoto K:
   An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes.
   Rheumatology 52(7):1172-82,2013
   
   
6. Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O, Kawaguchi Y, Kuwana M, Ogawa F, Takahashi H, Tanaka S, Sato S, Takehara K.:
   Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study.
   Mod Rheumatol 23(6):1076-84,2013
   
   
7. Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I.:
   Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren's syndrome.
   Mod. Rheumatol 23(5): 841-5, 2013
   
   
8. Iizuka M, Tsuboi H, Matsuo N, Kondo Y, Asashima H, Matsui M, Matsumoto I, Sumida T.:
   The crucial roles of IFN-g in the development of M3 muscarinic acetylcholine receptor induced Sjogren's syndrome-like sialadenitis.
   Mod Rheumatol 23(3):614-6, 2013
   
   
9. Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Chino Y, Matsumoto I, Sumida T.:
   Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor inhibitors: One year follow-up by low-field extremity MRI.
   Mod Rheumatol 23(4):782-7,2013
   
   
10. Ishiguro N, Yamamoto K, Katayama, K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Hara M, Iguratimod-Clinical Study Group:
    Concomitant iguratimod theraphy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-bline, placebo-controlled trial.
    Mod Rhumatol 23(3):430-439,2013
    
    
11. Anami A, Fukushima K, Takasaki Y, Sumida T, Waguri M, Murashima A, Wake N.:
    The predictive value of SS-A antibody titration in pregnant women with fetal congenital heart block.
    Mod Rhumatol 23(3):430-9,2013
    
    
12. Tsuboi H, Hagiwara S, Asashima H, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
    Validation of different sets of criteria for the diagnosis of Sjogren's syndrome in Japanese patients.
    Mod Rheumatol 23(2):219-25, 2013

2012年

1. Horikoshi M, Goto D, Seiji Segawa, Yohei Yoshiga, Keiichi Iwanami, Asuka Inoue, Yuki Tanaka, Matsumoto I, Sumida T.:
   Activation of invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
   PLoS One 7(12):e51215,2012
   
   
2. Sumida T, Iizuka M, Asashima H, Tsuboi H, Matsumoto I.：
   Pathogenic role of anti-M3muscarinic acetylcholine receptor immune response in Sjogren's syndrome.
   Presse Med 41(9 Pt 2):e461-6,2012
   
   
3. Inoue A, Matsumoto I, Tanaka Y, Umeda N, Tanaka Y, Mihara M, Takahashi S, Sumida T. :TIARP (TNFAIP9) deficiency leads to arthritis via IL-6 overproduction with enhanced NF-kB, STAT3 signaling and dysregulated apoptosis of macrophages.
   Arthritis Rheum 64(12):3877-85,2012
   
   
4. Thomas G, Grunewald P, Bach H, Cossarizza A, Matsumoto I.:
   The STEAP Protein Family: Versatile Oxidoreductases and Targets for Cancer Immunotherapy with Overlapping and Distinct Cellular Functions.
   Biology of the Cell 104(11):641-57,2012
   
   
5. Tsuboi H, Matsuo N, Iizuka M, Tsuzuki S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
   Analysis of IgG4 class switch-related molecules in IgG4-related disease.
   Arthritis Res Ther 14(4):R171,2012
   
   
6. Yamaguchi T, Ito S, Takano Y, Umeda N, Goto M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
   A case of a disseminated sporotrichosis patient treated with prednisolone, immunosuppressants, and tocilizumab under the diagnosis of rheumatoid arthritis.
   Intern Med 51(15):2035-9,2012
   
   
7. Hashizume M, Yoshida H, Tanaka K, Suzuki M, Matsumoto I, Sumida T, Mihira M.:
   Interleukine-6 regulates anti-arthritic effect of methotrexate via the reduction of SLC19A1 expression in mouse arthritis model.
   Arthritis Res Ther 14(2):R96,2012
   
   
8. Sakai R, Tanaka M, Nanki T, Watanabe K, Yamazaki H, Koike R, Nagasawa H, Amano K, Saito K, Tanaka Y, Ito S, Sumida T, Ihata A, Ishigatsubo Y, Atsumi T, Koike T, Nakajima A, Tamura N, Fujii T, Dobashi H, Tohma S, Sugihara T, Ueki Y, Hashiramoto A, Kawakami A, Hagino N, Miyasaka N, Harigai M, for the REAL Study Group.:
   Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anti-cytokine therapy with different target molecules.
   Ann Rheum Dis 71(11):1820-1826、2012
   
   
9. Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nagasawa H, Amano K, Nakajima A, Atsumi T, Koike T, Ihata A, Ishigatubo Y, Saito K, Tanaka Y, Ito S, Sumida T, Tohma S, Tamura N, Fujii T, Sugihara T, Kawakami A, Hagino N, Ueki Y, Hashiramoto A,  Nagasaka K, Miyasaka N,  Harigai M, for the REAL Study Group:
   T ime-dependent increased risk for serious infection from continuous use of TNF antagonists during three years in rheumatoid arthritis patients
   Arthritis Care & Research 64(8):1125-1134,2012
   
   
10. Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
    Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
    Lupus 21(8):890-5,2012
    
    
11. Hasebe N, Kawasaki A, Ito I, Kawamoto M, Hasegawa M, Fujimoto M, Furukawa H, Tohma S, Sumida T, Takehara K, Sato S, Kawaguchi Y, Tsuchiya N.:
    Association of UBE2L3 polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population.
    Ann Rheum Dis 71(7):1259-60,2012
    
    
12. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H.:
    Comprehensive Diagnostic Criteria (CDC criteria) for IgG4-related disease (IgG4-RD),2011
    Mod Rheumatol 22:21-30,2012
    
    
13. Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Umeda N, Tanaka Y, Sugihara M, Hayashi T, Ito S, Sumida T.
    Six-transmembrane epithelial antigen of prostate4 (STEAP4) is expressed on monocytes/neutrophils, and is regulated by TNF antagonist in patients with rheumatoid arthritis.
    Clin Exp Rheumatol 30(1):99-102,2012
    
    
14. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota Y, Toshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D.:
    A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.
    Mod Rhumatol 22:1-14,2012
    
    
15. Tsuboi H, Nakamura Y, Iizuka M, Matsuo N, Matsumoto I, Sumida T.:
    Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor
    Mod Rheumatol 22(2):264-271,2012
    
    
16. Kondo Y, Iizuka M, Wakamatsu E, Yao Z, Tahara M, Tsuboi H, Sugihara M,
    Hayashi T, Yoh K, Takahiashi S, Matsumoto I, Sumida T.:
    Overexpression of T-bet gene regulates murine autoimmune arthritis
    Arthritis Rheum 64:162-172,2012
    
    
17. Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, Kanamori A, Ochiai N, Miyazawa K, Sugihara M, Hayashi T, Goto D, Ito S, Sumida T.:
    Six-transmembrane epithelial antigen of prostate4(STEAP4) is TNFalpha-induced protein that regulates IL-6, Il-8, and cell proliferation in synovium from patients with rheumatoid srthritis
    Mod Rheumatol 22:128-136,2012
    
    
18. Okada Y, Shimane K, Kochi Y, Tahira T, Suzuki A, Higasa K, Takahashi A, Horita T, Atsumi T, Ishii T, Okamoto A, Fujio K, Hirakata M, Amano H, Kondo Y, Ito S, Takada K, Mimori A, Saito K, Kamachi M, Kawaguchi Y, Ikari K, Mohammed W O, Matsuda K, Terao C, Ohmura K, Myouzen K, Hosono N, Tsunoda T, Nishimoto N, Mimori T, Matsuda F, Tanaka Y, Sumida T, Yamanaka H, Takasaki Y, Koike T, Horiuchi T, Hayashi K, Kubo M, Kamatani N, Yamada R, Nakumura Y, Yamamoto K.:
    A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus erythematosus in Japanese.
    PLoS Genet 8(1): e1002455,2012
    

2011年

1. Koga M, Kawasaki A, Ito I, Furuya T, Ohashi J, Kyogoku C, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
   Cumulative Association of Eight Susceptibility Genes with Systemic Lupus Erythematosus in a Japanese Female Population.
   Journal of Human Genetics 56:503-507,2011
   
   
2. Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
   Toll-like receptor 7(TLR7) SNPs in the 3' untranslated region and intron additively contribute to susceptibility to systemic lupus erythematosus in a Japanese female population.
   Arthritis Res Ther 13(2):R41,2011
   
   
3. Yoshiga Y, Goto D, Segawa S, Horikoshi M, Hayashi T, Matsumoto I, Ito S, Taniguchi S, Sumida T.:
   Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
   Clin Exp Immunol 164(2):236-247,2011
   
   
4. Segawa S, Goto D, Yoshiga Y, Horikoshi M, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
   Involvement of NK 1.1-Positive {gamma}{delta}T Cells in Interleukin-18 Plus Interleukin-2-Induced Interstitial Lung Disease.
   Am J Res Cell Mol Biol 45(3):659-666,2011
   
   
5. Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T,Ogishima H, Hayashi T, Goto D, Ito S, Matsumoto I, Sumida T.:
   Importance of serine727 phosphorylated STAT1 in IFNgamma-induced signaling and apoptpsis of human salivary gland cells.
   Int J Rheum Dis 14:86-91,2011
   
   
6. Akashi N, Matsumoto I, Tanaka Y, Inoue A, Yamamoto K, Tanaka Y, Umeda N, Hayashi T, Goto D, Ito S, Sekiguchi K, Sumida T.:
   Comparative suppressive effect in models of autoimmune arthritis by tyrosine kinase inhibitors imatinib and nilotinib.
   Mod Rheumatol 21:267-275,2011
   
   
7. Hikami K, Kawasaki A, Ito I, Koga M, Ito S, Hayashi T, Matsumoto I, Tsutsumi A, Kusaoi M, Takasaki Y, Hashimoto H, Arinami T, Sumida T, Tsuchiya N.:
   Association of a functional polymorphism in the 3' untranslated region of SPI1 with systemic lupus erythematosus.
   Arthritis Rheum 63:755-763,2011
   
   
8. Miki H, Okamoto A, Ishigaki K, Sasaki O, Sumitomo S, Fujio K, Yamamoto K.:
   Cardiopulmonary arrest after severe anaphylactic reaction to second infusion of infliximab in a patient with ankylosing spondylitis.
   J Rheumatol 38(6):1220,2011
   

2010年

1. Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, Matsumoto I, Kusaoi M, Ohashi J, Graham R R, Matsuta K, Behrens T W, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
   Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population : a case-control association study.
   Arthritis Res Ther 12:R174,2010
   
   
2. Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T.:
   Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis.
   J Autoimmunity 35:383-389,2010
   
   
3. Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, Wu YL, Yu CY, Tang Y, Chen JY, Yang W, Wong M, Kawasaki A, Tsuchiya N, Sumida T, Kawaguchi Y, Howe HS, Mok MY, Bang SY, Liu FL, Chang DM, Takasaki Y, Hashimoto H, Harley JB, Guthridge JM, Grossman JM, Cantor RM, Song YW, Bae SC, Chen S, Hahn BH, Lau YL, Tsao BP.:
   Gender Specific Association of X-linked TLR7 with Male Systemic Lupus Erythematosus.
   PNAS 107(36):15838-15843,2010
   
   
4. Doki K, Homma M, Hori T, Tomita T, Hasegawa Y, Ito S, Fukunaga K, Kaneko M, Chiba S, Sumida T, Ohkohchi N, Kohda Y.:
   Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values.
   J Pharm Pharmacol 62(9):1185-1188,2010
   
   
5. Horikoshi M, Suzuki T, Sugihara M, Kondo Y, Tsuboi H, Uehara T, Hama M, Takase K, Ohno S, Ishigatsubo Y, Yoshida Y, Sagawa A, Ikeda K, Ota T, Matsumoto I, Ito S, Sumida T.: 
   Comparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
   Mod Rheumatol 20:556-560,2010
   
   
6. Chen Q, Muramoto K, Masaaki N, Ding Y, Yang H, Mackey M, Li W, Inoue Y, Ackermann K, Shirota H, Matsumoto I, Spyvee M, Schiller S, Sumida T, Gusovsky F, Lamphier M.Modern Rheumatology(in press)
   A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.
   Br J Pharmacol 160(2):292-310,2010
   
   
7. Hayashi T, Ito S, Goto D, Matsumoto I, Sumida T.:
   Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis.
   Mod. Rheumatol 20:548-555,2010
   
   
8. Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.:
   New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren’s syndrome.
   Clin Exp Immunol 162:53-61,2010
   
   
9. Ogishima H, Ito S, Tsutsumi A, Sugihara M, Goto D, Matsumoto I, Obata-Yasuoka M, Hamada H, Yoshikawa H, Takahashi H, Murashima A, Sumida T.:
   High dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report.
   Int J Rheum Dis 13(3):e32-e35,2010
   
   
10. Sumida T, Tsuboi H, Iizuka M, Nakamura Y, Matsumoto I.:
    Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjogren's syndrome.
    Autoimmunity Reviews 9:615-617,2010
    
    
11. Kawasaki A, Ito I, Ito S, Hayashi T, Goto D, Matsumoto I, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
    Association of TNFAIP3 polymorphism with susceptibility to systemic lupus erythematosus in a Japanese population.
    J Biomed Biotechnol Epub 2010 May 27
    
    
12. Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Sugihara M, Horikoshi M, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
    New low-field extremity MRI, compacTscan: comparison with whole body 1.5 tesla conventional MRI.
    Mod Rheumatol 20(4):331-336,2010
    
    
13. Tashiro T, Nakagawa R, Inoue S, Omori-Miyake M, Chiba T, Fujii S, Shimizu K, Mori K, Yoshiga Y, Sumida T, Watarai H, Taniguchi M.
    Induction of Th1-biased cytokine production by α-carba-GalCer,a neoglycolipid ligand for natural killer T cells.
    Int Immunol 22(4):319-328,2010
    
    
14. Umeda N, Ito S, Hayashi T, Goto D, Matsumoto I, Sumida T.:
    A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment.
    Intern Med 49:187-189,2010
    
    
15. Ito I, Kawasaki A, Ito S, Kondo Y, Sugihara M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Takasaki Y, Hashimoto H, Matsuta K, Sumida T, Tsuchiya N.:
    Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population.
    Ann Rheum Dis 69(5):936-937,2010
    
    
16. Segawa S, Goto D, Yoshiga Y, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
    Inhibition of transforming growth factor-b signaling attenuates IL-18 plus IL-2-induced interstitial lung disease in mice.
    Clin Exp Immunol160:394-402,2010
    
    
17. Wang Y, Ito S, Chino Y, Goto D, Matsumoto I, Murata H, Tsutsumi A, Hayashi T, Uchida K, Usui J, Yamagata K,Sumida T.:
    Laser Microdissection-based Analysis of Cytokine Balance in the Kidneys of Patients with Lupus Nephritis
    Clin Exp Immunol 159(1):1-10,2010
    
    2009年
    

1.Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, Tanaka Y, Minami R, Hayashi T, Goto D, Ito S, Nishimura Y, Sumida T.:
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Arthritis Res Ther. 11:R167,2009

2.Inoue A, Matsumoto I, Tanaka Y, Iwanami K, Kanamori A, Ochiai N, Goto D, Ito S, Sumida T.:
Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis.
Arthritis Res Ther 11(4):R118. Epub 2009 Aug 6

3.Segawa S, Goto D, Yoshiga Y, Hayashi T, Matsumoto I, Ito S, Sumida T.:
Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis.
Int J Mol Med 24(4):481-486,2009

4. Kawaguchi Y, Nakamura Y, Matsumoto I, Nishimagi E, Kamatani N, Satoh T, Kuwana M, Sumida T, Hara M.:
Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility
Ann Rheum Dis 68:710-714,2009

5.Kondo Y, Ito S,Ohi Y, Satou H, Hiraoka T, Tsuboi H, Sugihara M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Atypical Cogan's Syndrome with aortitis.
Intern Med 48:1093-1037,2009

6.Wakamatsu E, Matsumoto I, Yoshiga Y, Hayashi T, Goto D, Ito S, Sumida T.:
Altered peptide ligands regulate type II collagen-induced arthritis in mice
Mod Rheumatol 19:366-371,2009

7.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A new low-field extremity magnetic resonance imaging and proposed compact MRI score: Evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis.
Mod Rheumatol 19:358-365,2009

8.Horikoshi M, Ito S, Ishikawa M, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show reduced or insufficient response to infliximab.
Mod Rheumatol 19:229-234, 2009

9.Kobayashi T, Murasawa A, Ito S, Yamamoto K, Komatsu Y, Abe A, Sumida T, Yoshie H. Cytokine gene polymorphisms associated with rheumatoid arthritis and periodontitis in Japanese adults. J Periodontology 80:792-799,2009

10.Ito I, Kawasaki A, Ito S, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Geoffrey Hom, Robert R. Graham, Takasaki Y, Hashimoto H, Ohashi J, Timothy W. Behrens, Sumida T, Tsuchiya N.:
Replication of the Association between C8orf13-BLK Region and Systemic Lupus Erythematosus in a Japanese Population.
Arthritis Rheum 60(2):553-558,2009

11.Tsutsumi A, Kobayashi T, Ito S, Goto D, Matsumoto I, Yoshie H, Sumida T.: Mannose binding lection gene polymorphisms and the severity of chronic periodontitis. Jap J Clin Immunol 32:48-52,2009

12.Tanaka-Watanabe Y, Matsumoto I, Iwanami K, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
B cell play crucial role as antigen presenting cells and collaborationg with inflammatory cytokines in glucose-6-phoaphate isomerase-induced arthritis.
Clin Exp Immunol 155:285-294,2009


2008年
1.Nakamura Y, Wakamatsu E, Matsumoto I, Tomiita M, Kohno Y, Mori M, Yokota S, Goto D, Ito S, Tsutsumi A, Sumida T.:
High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjogren's syndrome
Ann Rheum Dis 67(1):136-137,2008

2.Tatsumura M, Mishima H, Shiina I, Hara Y, Nishiura Y, Ishii T, Ochiai N, Ishii W, Sumida T.: Femoral nerve palsy cuased by a huge iliopectineal synovitis extending to the iliac fossa in a rheumatoid arthritis case. Mod Rheumatol 18:81-85,2008

3.Kohno M, Tsutsumi A, Matsui H,Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Ito S, Suguro T, Sumida T.: Interleukin-17 gene expression in patients with rheumatoid arthritis Mod Rheumatol 18:15-22,2008


4.Iwanami K, Matsumoto I, Watanabe Y, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T.:
Crucial role of IL-6/IL-17 cytokine axis in the induction of arthritis by glucose-6-phosphate-isomerase.
Arthritis Rheum 58(3):754-763 ,2008

5.Ishii W, Ito S, Kondo Y, Tsuboi H, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T, Okoshi Y, Hasegawa Y, Kojima H, Sakashita S, Aita K, Noguchi M.:
Intravascular large B-cell lymphoma with acute abdomen as a presentingsymptom in a patient with systemic lupus erythematosus.
J Clin Oncol 26(9):1553-5,2008

6.Matsui H, Tsutsumi A, Sugihara M, Suzuki T, Iwanami K, Kohno M, Goto D, Matsumoto I, Ito S, Sumida T.:
Visfatin(pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis
Ann Rheum Dis 67(4):571-572,2008

7.Wang Y, Ito S, Chino Y, Iwanami K, Yasukochi T, Goto D, Matsumoto I, Hayashi T, Uchida K, Sumida T.:
Use of Laser Microdissection in the Analysis of Renal-infiltrating T cells in MRL/lpr Mice
Mod Rheumatol 18:385-393,2008

8.Furuya T, Matsumoto I, Tsuchiya N, Hakoda M, Ichikawa N, Higami K, Nanke Y, Sumida T, Kamatani N, Kotake S.:
Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis
Clin Exp Rheumatol 26(5):918-921,2008

9.Matsumoto I, Zhang H, Yasukochi T, Iwanami K, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Therapeutic effects of antibodies to TNF alpha and IL-6 and CTLA-4 Ig in mice with glucose-6-phosphate isomerase-induced arthritis
Arthritis Res Ther 10(3):R66,2008

10.Ishii W, Matsuda M, Shimojima Y, Itoh S, Sumida T, Ikeda S-I.: Flow cytometric analysis of lymphocyte subpopulations and Th1/Th2 balance in patients with poly myositis and dermatomyositiis. Intern Med 47(18)1593-1599,2008

11.Yoshiga Y, Goto D, Segawa S, Ohnishi Y, Matsumoto I, Ito S, Tsutsumi A, Taniguchi M, Sumida T.:
Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis
Int J Mol Med 22:369-374,2008

12. Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D, Matsumoto I, Ito S, Tsutsumi A, Koga M, Arinami T, Robert R Graham, Geoffrey Hom, Takasaki Y, Hashimoto H, Timothy W Behrens, Sumida T, Tsuchiya N.:
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of STAT1-STAT4 region.
Arthritis Res Ther 10:R113,2008

13. Suzuki T, Tsutsumi A, Suzuki E, Sugihara M, Muraki Y, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.: Tristetraprolin(TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals Mod Rheumatol 18:472-479,2008
14.Iwanami K, Matsumoto I, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Arthritogenic T cell epitope in glucose-6-phosphate isomerase (GPI)-induced arthritis.
Arthritis Res Ther 10(6):R130,2008

2007年

1.Sumida T, Wakamatsu E, Nakamura Y, Matsumoto I.: Autoantibodies against muscarinic acetylcholine receptor in patients with Sjogren's syndrome.(review) In Textbook of Autoantibodies Second Edition ed. by Y. Shoenfeld, M. E. Gershwin and P. L. Meroni. Elsevier, 681-686, 2007

2.Wakamatsu E, Nakamura Y, Matsumoto I, Goto D, Ito S, Tsutsumi A, Sumida T.:
DNA microarray analysis of labial salivary gland of patients with Sjogren's syndrome
Ann Rheum Dis 66:844-845,2007

3.Yamada H, Nakagawa Y, Wakamatsu E, Sumida T, Yamachika S, Nomura Y, Mishima K, Saito I.: Efficacy prediction of cevimeline in patients with Sjogren's syndrome. Clin Rheumatol 26:1320-1327,2007

4.Yamada H, Ishii W, Ito S, Iwanami K, Ogishima H, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.: Sarcoid myositis with muscle weakness as a presenting symptom Mod Rheumatol 17:243-246，2007

5. Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.: Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Intern Med 46, 771-774, 2007

6.Kobayashi T, Ito S, Yasuda K, Kuroda T, Yamamoto K, Sugita N, Tai H, Narita I, Gejyo F, Yoshie H.: The Combined Genotypes of Stimulatory and Inhibitory Fcγ Receptor Associated with Systemic Lupus Erythematosus and Periodontitis in Japanese
J Periodontol 78(3) 467-474, 2007

7.Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, Hayashi T, Chino Y, Ishii W, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T.: Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis. Arthritis Rheum 56(7):2160-2169,2007

8.Takana Y, Yamamoto K, Takeuchi T, Nishimoto N, Miyasaka N, Sumida T, Shima Y, Takada K, Matsumoto I, Saito K, Koike T. A multi-center phase I/II trial of rituximab for refractory systemic lupus erythematosus Mod Rheumatol(in press)

9.Enami T, Suzuki T, Ito S, Yoshimi A, Sugihara M, Mamura M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Sumida T. Successful treatment of refractory thrombotic thrombodytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13. Intern Med 46:1033-1037, 2007

10.Hayashi T, Matsumoto I, Yasukochi T, Mamura M, Goto D, Ito S, Tsutsumi A, Sumida T.: Biased usage of synovial immunoglobulin heavy chain variable region 4 by the anti-glucose-6-phosphate isomerase antibody in patients with rheumatoid arthritis. Int. J. Mol. Med.20(2):247-253,2007

11.Kobayashi T, Ito S, Kuroda T, Yamamoto K, Sugita N, Narita I, Sumida T, Gejyo F, Yoshie H.: The Interleukin-1 and Fcg Receptor Gene Polymorphisms in Japanese Patients with Rheumatoid Arthritis and Periodontitis J. Periodont. 78(12):2311-2318,2007

12.Kuroda T, Hirose S, Tanabe N, Sato H, Nakatsue T, Ajiro J, Wada Y, Murakami S, Hasegawa H, Ito S, Sakatsume M, Nakano M, Gejyo F.: Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy Mod Rheumatol 17:206-212,2007

13.Nakayamada S, Saito K, Umehara H, Ogawa N, Sumida T, Ito S, Minota S, Nara H, Kondo H, Okada J, Mimori T, Yoshifuji H, Sano H, Hashimoto N, Sugai S, Tanaka Y.:
Efficacy and Safety of Mizoribine for the Treatment of Sjogren’s Syndrome − A Multicenter Open-label Clinical Trial
Mod Rheumatol 17(6):464-469,2007


2006年
1.Naito Y, Matsumoto I, Wakamatsu E, Goto D, Ito S, Tsutsumi A, Sumida T.: Altered peptide ligants regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjogren's Syndrome Ann. Rheum. Dis. 65:269-271,2006

2.Chino Y, Murata H, Goto D, Matsumoto I, Tsutsumi A, Sakamoto T, Ohtsuka M, Sekisawa K, Ito S, Sumida T.: T cell receptor BV gene repertoire in lymphocytes from bronchoalveolar lavage fjuid of polymyositis/dermatomyositis patients with interstitial pneumonitis. Int. J. Mol. Med. 17:101-109,2006

3.Yoshioka H, Ito S, Handa S, Tomiha S, Kose K, Haishi T, Tsutsumi A,Sumida T.: Low-fied compact magnetic resonance imaging system for the hand and wrist in rheumatoid arthritis. JMRI 23:370-376,2006

4.Suzuki E, Tsutsumi A, Goto D, Matsumoto I, Ito S, Otsu M, Onodera M, Takahashi S, Sato Y, Sumida T.:
Gene transduction of tristetraprolin or its active domain reduces TNF-α production in Jurkat T cells.
Int.J.Mol.Med.17(5)801-809,2006

5. Ito S, Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Diagnosis of Chlamydia-induced reactive arthritis
Intern Med(letter)45(1)37-37,2006

6.Kori Y., Matsumoto I., Hua Zhang., Yasukochi T., Hayashi T., Iwanami K., Goto D., Ito S., Tsutsumi A., Sumida T.:
Characterization of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis
Ann. Rheum. Dis.65:968-969,2006

7.Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, Miyamoto A, Honda S, Matsumoto I, Koyama A, Sumida T, Shibuya A.: Critical role of M.tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice Immunology 118 233-239,2006

8.Ito S, Gross WL, Reinhold-Keller E, Gause A, Aries P, Ru¨ther W, Mansoury T, Awad R, Badawy S, Murasawa A, Gejyo F.: Rheumatology in Japan, Germany, and Egypt: Comparison of Medical Practices. Acta Med Biol 54(2):51-58,2006

9.Suzuki E, Tsutsumi A, Sugihara M, Mamura M, Goto D, Matsumoto I, Ito S, Ikeda K, Ochiai N, Sato Y, Sumida T.: Expression of TNF-α, tristetraprolin, T-cell intracellular antigen-1 and Hu antigen R genes in synobium of patients with rheumatoid arthritis. Int.J.Mol.Med. 18:273-278,2006

10.Tsutsumi A, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.: Significnace of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other phospholipids antibody assays. Mod.Rheumatol.16:158-164,2006

11.Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, Ito S, Tsutsumi A, Sumida T.: Overexpression of phosphorylated stat1-α in labial salivary glands of patients with Sjogren's Syndrome Arthritis Rheum 54(11):3476-3484,2006

12.Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, Uemura Y, Nishimura Y, Sumida T.: Altered peptide ligands control type 2collagen-reactive T cells from RA patients Mod.Rheumatol.16:226-228,2006

13. Kurata M., Nozue M., Seino K.-I., Murata H., Sumida T., and Fukao K.： Indications for surgery in intestinal Behcet's disease. Hepatogastroenterology.53(67):60-3,2006


2005年
1.Takahashi R., Tsutsumi A., Ohtani K., Muraki Y., Goto D., Matsumoto I., Wakamiya N., and Sumida T.:
Association of mannose-binding lection(MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus.
Ann. Rheum. Dis.64(2):311-314,2005

2.Ota M., Mizukami K., Hayashi T., Sumida T., Asada T.: Brain magnetic resonance imaging and single photon emission computerized tomography findings in a case of relapsing polychondritis showing cognitive impairment and personality changes. Prog Neuropsychopharmacol Bio Psychiatry.29(2):347-349,2005

3.Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., Ito S.,Tsutsumi A., Sumida T.: Muscariinic acetylcholine recepter auto antibodies in patients with Sjogren's Syndrome Ann. Rheum. Dis.64（3):510-511,2005

4.Tomoo T., Tsutsumi A., Yasukochi T., Ikeda T., Ochiai N., Ozawa K., Shibanaka Y., Ito S., Matsumoto I., Goto D., Sumida T.: Analysis of abnormally expressed genes in synovium from patients with rheumatoid arthritis using a column gel electrophoresis-coupled subtractive hybridization technique. Int. J. Mol. Med.15(3):453-457,2005

5.Suzuki T., Muraki Y., Yasukochi T., Hua Zhang., Kori Y., Wakamatsu E., Hayashi T., Goto D., Ito S., Tsutsumi A., Sumichika H., Sumida T., Matsumoto I.: Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys Autoimmunity Reviews 4:475-478,2005

6.Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, Ito S, Tsutsumi A, Sumida T.: Clinical Characteristics of Anti-Glucose-6-Phosphate Isomerase Antibodies positive Japanese Patients with Rheumatoid Arthritis Mod Rheumatol.15:258-263,2005

7.Matsumoto I, Muraki Y, Yasukochi T, Hua Zhang, Kori Y, Hayashi T, Goto D, Ito S, Tsutsumi A, Ikeda K, Sumichika H, Sumida T.: The exploration of joint-specific immunoreactions on immunoglobulins G of anti-glucose-6-phosphate isomerase antibody-positive patients with rheumatoid arthritis Int. J. Mol. Med . 16(5):793-800,2005

8.Matsumoto I, Hua Zhang, Muraki Y, Hayashi T, Yasukochi T, Kori Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
A functional variant of Fcy receptor IIIA is associated with rheumatoid arthritis in anti-glucose-6-phosphate isomerase antibodies-positive individuals
Arthritis. Res. Ther. 7:1183-1188,2005

9.Takahashi R, Tsutsumi A, Ohtani K, Wakamiya N, Sumida T.:
Mannose-binding lectin variant alleles are not a risk factor for arterial thrombosis in Japanese patients with systemic lupus erythematosus
Mod.Rheumatol.(letter)15:459-460,2005

10.Miyahara S, Ito S, Soeda A, Chino Y, Hayashi T, Takahashi R, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Two cases of systemic lupus erythematosus complicated with colonic ulcers.
Intern Med. 44(12)1298-1306,2005

11.Ohnishi Y, Tsutsumi A, Goto D, Ito S, Matsumoto I, Taniguchi M,Sumida T.:
TCRVa14+NKT cells function as effector T cells in collagen-induced arthritis mice
Clin. Exp. Immunol. 141:47-53,2005

12.Ito S, Sumida T.:
Management of Chlamydia induced reactive arthritis(Editorial)
Intern Med(in press)

13.Tsutsumi A, Takahashi R, Sumida T.:
Mannose binding lectin:genetics and autoimmune disease.
Autoimmunity Reviews. 4:364-372,2005

14.Sumida T.:
Comments to the editor concerning paper by Naito, Yet al.
Ann. Rheum. Dis.(in press)

15.Kitagawa M, Goto D, Mamura M, Matsumoto I, Ito S, Tsutsumi A, Sumida T.: Inhibitory peptides of CD40/CD154 interaction. Mod.Rheumatol.15:423-426,2005

16.Suzuki E, Hayashi T, Ito S, Miyazaki K, Yamazaki H, Machino T, Takahashi R, Chino Y, Goto D, Matsumoto I, Tsutsumi A, Sato Y, Sumida T.:
A case of pulmonary hypertension associated with systemic lupus erythematosus without anti-ribonucleoprotein antibodies
ACTA MEDICA et BIOLOGICIA 53(3)87-93,2005

2004年
1.Tsutsumi A., Adachi Y., Murata H., Kojo S., Shibuya K., Nakamura H., and Sumida T.:
G0S24, a gene that regulates TNFa production,is highly expressed in synovial tissue from patients with rheumatoid arthritis. J. Rheumatol. 31(6):1044-9,2004

2.Takahashi R., Tsutsumi A., Ohtani K., Goto D., Matsumoto I., Ito S., Wakamiya N.,and Sumida T.:
Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus.
Clin. Exp. Immunol.136(3):585-590,2004

3.Muraki Y., Tsutsumi A., Takahashi R., Suzuki E., Hayashi T., Chino Y., Goto D., Matsumoto I.,Murata H., Noguchi E., and Sumida T.:
Polymorphisms of IL-1β Gene in Japanese Patients with Sjogren’s Syndrome and Systemic Lupus Erythematosus.
J. Rheumatol.31:720-725,2004

4.Muraki Y., Matsumoto I., Chino Y., Hayashi T., Suzuki E., Goto D., Ito S., Murata H., Tsutsumi A., Sumida T.:
Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies.Possible mechanism of autoantibody production
Biochem. Biophys. Research. Commun.323(2):518-522,2004

5. Asatsuma M., Ito S., Watanabe M., Takeishi H., Momura S., Wada Y., Nakano M., Gejyo F., Igarashi A.:
Increase in the ratio of matrix metalloprotease-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with Primary Sjo¨gren’s syndrome.
Clin Chim Acta 345:99-104, 2004

6.Kato T., Asahara H., Kurokawa MS., Fujisawa K., Hasunuma T., Inoue H., Tsuda M., Takahashi S., Motokawa S., Sumida T., Nishioka K.:
HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.
Clin Rheumatol.23(5)400-9,2004

7.Kuroda T., Ohbayashi H., Murakami S., Ito S., Sakatsume M., Ueno M., Nishi S., Nakano M., Gejyo F.:
A case of Takayasu arteritis complicated with glomerulonephropathy mimicking membranoproliferative glomerulonephritis
Clin Rheumatol 23:536-540,2004

8.Ito S., Sumida T.:
Interstitial Lung Disease Associated with Leflunomide. Intern Med 43(12):1103-1104,2004

9.Iguchi S., Kasai A., Kishimoto H., Suzuki K., Ito S., Ogawa Y., Nishi S., Gejyo F., Ohno Y.:
Thrombosis in inferior vena cava (IVC) due to intra-cyst hemorrhage into a hepatic local cyst with autosomal dominant polycystic kidney disease(ADPKD).Intern Med 43:209-212,2004

10.Wada Y., Murayama S., Hirose S., In H., Kuroda T., Ito S., Nakano M., Gejyo F.:
A case of pneumatosis cystoides intestinalis in a patient with polymyositis and interstitial pneumonia. Mod Rheumatol 14:260-263,2004

11.Alchi B., Sekiguchi T., Ogino S., Nishi S., Ito S., Mori H., Ueno M., Gejyo F.:
A 70-year-old man with weight loss, dry mouth and renal insufficiency. Nephrol Dial Transplant 19:2661-2664,2004

12.Kanazawa M., Wada Y., Ohno T., In H., Yahata K., Izumi J., Tanaka H., Ito S., Ueno M., Nakano M., Gejyo F.:
Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis : a case report. Clin Rheumatol 23:456-459,2004

13.Yoko W., Ito S., Mitsuhiro U., Nakano M., Arakawa M., Gejyo F.:
Renal outcome and predictors of clinical renal involvement in patients with silent nephritis. Nephron 98:105-111,2004


2003年
1 . Ohnishi Y., Tsutsumi A., Sakamaki T., and Sumida T.:
T cell epitopes of type II collangen in HLA-DRB1*0101 or DRB1*0405-positive Japanese patients with rheumatoid arthritis. International Journal of Molecular Medicine 11:331-335,2003

2 .Ohnishi Y., Tsutsumi A., and Sumida T.: Antibodies to type II collagen and their association with HLA DR1 alleles in Japanese patients with rheumatoid arthritis. Mod. Rheumatol. 13:69-72,2003

3.Adachi Y., Tsutsumi A., Murata H., Takemura H., Chino Y., Takahashi R., Ebitsuka T., and Sumida T.:Behcet's disease accompanied by myelodysplastic syndrome with trisomy 8: Two case reports and review of 15 Japanese cases. Mod. Rheumatol. 13:90-94, 2003

4 .Matsumoto I., David M Lee., Raphaela Goldbach-Mansky., Sumida T., Carol A Hitchon., Peter H. Schur., Ron J Anderson., Jonathan S Coblyn., Michael E Weinblatt., Michael Brenner., Bernard Duclos., Jean-Louis Pasquali., Hani El-Gabalawy., Diane Mathis. , and Christophe Benoist.:Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders
Arthritis and Rheumatism. 48:944-954, 2003

5.Yoshida K., Tsutsumi A., Ohnishi Y., Akimoto T., Murata H., and Sumida T.:T cell epitopes of prothrombin in patients with antiphospholipid syndrome. Ann. Rheum. Dis. 62:1-2,2003

6.Tsutsumi A., Ikegami H., Takahashi R., Murata H., Goto D., Matsumoto I., Fujisawa T., and Sumida T.:
Mannose binding lectin gene polymorphism in patients with type I diabetes. Human Immunology. 64:621-624, 2003

7. Kojo S., Tsutsumi A., Goto D., and Sumida T.:
Low expression levels of soluble CD1d gene in patients with rheumatoid arthritis.
The journal of Rheumatology. 30:2524-2528,2003

8. Murata H., Adachi Y., Ebitsuka T., Chino Y., Takahashi R., Hayashi T., Goto D., Matsumoto I., Tsutsumi A., Akaza H., and Sumida T.:
Reiter's syndrome following intravesical Bacille bilie de Calmette-Guerin treatment for superficial bladder carcinoma. Report of six cases Mod. Rheumatol. 14:82-86,2004

9.Sumida T.:
Immunological abnormality and regulation in patients with Sjogren's syndrome.
Arthritis Res Ther. 5(Suppl 3):159,2003

10.Shibuya K., Shirakawa J., Kameyama T., Honda S.-1.,
Tahara-Hanaoka S., Miyamoto A., Onodera M., Sumida T.,
Nakauchi H., Miyoshi H., and Shibuya A. CD226(DNAM-1)
is involved in LFA-1 costimlatory signal for naive T cell
differentiation and proliferation.
J. Exp. Med. 198:1829-1839,2003

11.Arakaki R., Ishimaru N., Saito I., Kobayashi M., Yasui N., Sumida T., and Hayashi Y.:
Development of Autoimmune Exocrinopathy Resembling Sjoren's Syndrome in Adoptively Transferred Mice With Autoreactive CD4+T Cells. Arthritis and Rheumatism. 48:3603-3609,2003

12.Ito S., Kuriyama H., Iino N., Iguchi S., Shimada H., Ueno M., Narita I., Nakano M., Nishi S., Karasawa R., Gejyo F.:
Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
Clin Exp Nephrol 7:290-295, 2003


2002年
1.Yasuda S., Tsutsumi A., Atsumi T., Maria L.Bertolaccini., Ichikawa K., Munther A. Khamashta., Graham R.V. Hughes., and Koike T. :Gene Polymorphisms of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Patients with Antiphospholipid Antibodies　J. Rheumatol.29(6):1192-1197,2002

2.Matsumoto I., Maccioni M., David M. Lee., Madelon Maurice., Barry Simmons., Michael Brenner., Diane Mathis., and Christophe Benoist. : How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nature Immunol. 3(4):1-7,2002

3. Shimizudani N., Murata H., Keino H., Kojo S., Nakamura H., Morishima Y., Sakamoto T., Ohtsuka M., Sekizawa K., Sumida M., Sumida T., and Matsuoka T.: Conserved CDR 3 Region of T Cell Receptor BV Gene in Lymphocytes from Bronchoalveolar Lavage Fluid of Patients with Idiopathic Pulmonary Fibrosis. Clin. Exp. Immunol.129 (1):140-149,2002

4. Matsumoto I., and Sumida T.: B cells and Immunoglobulins dependent mechanisms in rheumatoid arthritis. Therapeutic Apheresis. (in press)

5. Tsutsumi A., Ebitsuka T., Murata H., Takemura H., and Sumida T.: A case of HLA B27 positive coxitis diagnosed 15 years after onset. Mod. Rheumatol. 12:349-353 ,2002

6.Yagi K., Furuhashi M., Aoki H., Goto D., Kuwano H., Sugamura K., Miyazono K., and Kato M.: c-myc is a downstream target of the Smad pathway. J. Biol.Chem. 277(1):854-861,2002

7.Murata H., Matsumura R., Koyama A., Sugiyama T., Sueishi M., Shibuya K., Tsutsumi A., and Sumida T.: T Cell Receptor of T Cells in the Kidneys of Patients with Lupus Nephritis. Arthritis Rheum.46(8):2141-2147,2002

8.Yasukochi T., Ozawa K., Sato M., Sumida T., and Shibanaka, Y.: Evaluation of the improvement of IGC technique.
Nucleic Acids Res, Suppl. 2:199-200, 2002

9. Kurata M., Nozue M., Seino K.-I., Murata H., Sumida T., and Fukao K.： Indications for surgery in intestinal Behcet's disease. Hepatogastroenterology. ( in press)

10.Matsumoto I., Sumida T.: B Cells and Immunoglobulins Dependent Mechanisms in Rheumatoid Arthritis: A Possible Rationale of the Extracorporeal Immunomodulation for Rheumatoid Arthritis. Therapeutic Apheresis 6:317-319,2002


2001年
1. Oishi, Y., Sumida, T., Sakamoto, A., Kita, Y., Kurasawa, K., Nawata, Y., Takabayashi, K., Takahashi, H., Yoshida, S., Taniguchi, M., Saito, S., and Iwamoto, I. Selective reduction and recovery of invariant Va24JaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 28:275-283, 2001.

2. Akimoto, T., Akama, T., Saito, M., Kono, i., and Sumida, T. Anti-prothorombin autoantibodies in gestational toxicosis and abortion. Am. J. Med. 110:188-191.2001

3. Keino, H., Takeuchi, M., Kojo, S., Suzuki, J., Sakai, J., Nishioka, K., Sumida, T., and Usui, M. Identification of regulatory T cells among in vivo expanded ocular T cells in mice with experimental autoimmune uveoretinitis. Clin. Exp. Immunol. 124: 1-8, 2001

4. Kojo, S., Adachi, Y., Keino, H., Taniguchi, M., and Sumida, T. Dysfunction of TCR AV24AJ18+BV11+ double negative regulatory NKT cells in autoimmune diseases. Arthritis Rheum. 44(5):1127-1138

5. Tsutsumi, A., Atsumi, T., Yamada, H., Hirayama-Kato, E., Ichikawa, K., Fujimoto, S., and Koike, T. Anti-phosphatidylserine/prothorombin antibodies are not frequently in patients with unexplained recurrent miscarriages. Am. J. Reprod. Immunol. 46(3):242-244.2001

6. Tsutsumi, A., Sasaki, K., Wakamiya, N., Ichikawa, K., Atsumi, T., Ohtani, K., Suzuki, Y., Koike, T., and Sumida, T. Mannose binding lectin gene: Polymorphisms in japanese patients with systemic lupus erythematosus, rheumatoid arthritis and sjogren's syndrome. Genes Immun. 2(2):99-104.2001

7. Kitagawa, M., Suzuki, H., Adachi, Y., Nakamura H., Yoshino, S., and Sumida, T. Interferon-gamma enhances interleukin-12 production in rheumatoid synovial cells via CD40-CD154 dependent and independent pathways. J. Rheumatol. 28(8):1764-1771.2001

8. Shimizudani, N., Murata, H., Kojo, S., Adachi, Y., Keino, H., Tsuchida, F., Sumida, M., Kawamata, M., Sumida, T., Matsuoka, K. Analysis of T cell receptor Vbeta gene expression and clonality in bronchoalveolar fluid lymphocytes from a patient with chronic eosinophilic pneumonitis. Lung 179:31-41.2001

9. Murata, H., and Sumida, T. Quantitative analysis of fetal michrochimerism in Japanese women with systemic sclerosis. Mod. Rheumatol. 11:259-260.2001

10. Nishio, M., Oda, A., Koizumi, K., Satoh, I., Sato, Y., Endoh, T., Tsutsumi, A., Fujihara, M., Ikebuchi, K., Ikdeda, H., Koike, T., and Sawada, K. Stem cell factor prevents Fas-mediated apoptosis of human erythroid precursor cells with Src-family kinase dependency. Exp. Hematol. 29: 19-29, 2001.

11. Takahashi, R., Shimazak, Y., and Endoh, M. Influence of acidosis on PIE of UD-CG 212 CI in dog heart. J. Pharmacol. Exp. Ther. 298(3):1060-1066.2001


2000年
1. Wang, M., Keino, H., Matsumoto, I., Kurokawa, M., Kato, T., Nishioka, K., and Sumida, T. A single cell analysis of Fas-ligand positive T cells in rheumatoid synovium. J. Rheumatol. 27:311-318,2000.

2. Enomoto, M., Takemura, H., Suzuki, M., Yuhara, T., Akama, T., Yamane, K., Sumida, T. Palmar Fasciitis and polyarthritis associated with gastric carcinoma: a paraneoplastic syndrome. (Case report). Int. Medicine.39(9):754-757,2000

3. Yuhara, T., Takemura, H., Akama, T., Yamane, K., and Sumida, T. The relationship between serum immunoglobulin and pulmonary involvement in systemic sclerosis. J.Rheumatol.27:1207-1214,2000

4. Suzuki, M., Takemura, H., Suzuki, H., and Sumida, T. Light chain determines the fine specificity of anti-dsDNA IgG autoantibodies obtained by a phage-display method. Biochem. Biophys. Research. Commun. 271: 240-243, 2000.

5. Keino, H., Sakai, J.-I., Nishioka, K., Sumida, T., and Usui, M. Clonally accumulating ocular T cells in patient with Behcet's disease. Am. J. Ophthal. 130: 243-245, 2000

6. Tsutsumi, A., et al. Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2-glycoprotein I. J.Rheumatol. 27: 391-369, 2000

7. Matsuura, E., Inagaki, J., Kasahara, H., Yamamoto, D., Atsumi, T., Kobayashi, K., Kaihara, K., Zhao, D., Ichikawa, K., Tsutsumi, A., Yasuda, T., Triplett, DA., Koike, T. Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship. Int. Immunol. 12:1183-1192, 2000

8. Yin, W., Hasunuma, T., Kobata, T., Sumida, T., Nishioka, K:. Synovial hyperplasia in HTLV-1 associated arthropathy is induced by tumor necrosis factor-alpha produced by HTLV-1 infected CD68+ cells. J. Rheumatol. 27: 874-881, 2000

9. Yuhara, T.,Takemura, H., Akama, T., Yamane, K., Sumida T:Necrotizing fasciitis caused by streptococcus pneumoniae in mixed connective tissue disease.Mod. Rheumatol. 10:180-182,2000.

10. Kojo, S., Adachi, Y., Tsutsumi, A., and Sumida, T. Alternative splicing forms of human CD1D gene in mononuclear cells. Biochem. Biophys. Research. Commun. 276: 107-111, 2000

11. Sumida, T. T cell and autoantigens in Sjogren's syndrome (review). Modern Rheumatol. 10: 193-198, 2000

12. Okamoto, K., Kobayashi, T., Kobata, T., Hasunuma, T., Kato, K., Sumida, T., and Nishioka, K. Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes. Rheumatology 39: 471-480, 2000

13. Morimoto, S., Hashimoto, H., Yamanaka, K., Tokano, Y., Nishimura, Y., Sawada, S., Kamatani, N., Sumida, T., Yoshizaki, K., Nakasawa, K., and Miyasaka, N. The multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus. Modern Rheumatol. 10: 235-239, 2000

14. Shibuya A., Sakamoto N., Shimizu Y., Shibuya K., Osawa M., Hiroyama T., Eyre H. J., Sutherland G. R., Endo Y., Fujita T., Miyabayashi T., Sakano S., Tsuji T., Nakayama E., Phillips J. H., Lanier L. L., and Nakauchi H. Fca/m receptor mediates endocytosis of IgM-coated microbes. Nature Immunol. 1: 441-446, 2000


1999年
1. Akimoto, T., Akama, T., Kono, I., Yamane, K., and Sumida, T. Detergent and antigen fragility affect the ELISA for measurement of anti-prothrombin autoanticodies. J. Rheumatol. 26: 580-587, 1999.

2. Maeda, T., Keino, H., Asahara, H., Taniguchi, M., Nishioka, K., and Sumida, T. Decreased TCR AV24AJ18+ double negative T cells in rheumatoid synovium. Br. J. Rheumatol. 38:186-188, 1999.

3. Kobayashi, T., Okamoto, K., Kobata, T., Hasunuma, T., Sumida, T., and Nishioka, K. TNF_ regulates Fas-mediated apoptosis signaling pathway in synovial cells. Arthritis Rheum. 42:519-526, 1999.

4. Uehara, R., Fujisawa, K., Kezuka, T., Sakai, J.-I., Nishioka, K, Sumida, T., and Usui, M. Conserved TCR CDR3 region of infiltrating T cells in experimental autoimmune uveoritinitis. Ophth. Research 31:249-255, 1999.

5. Sumida, T. Sjogren's syndrome. Int. Medicine. 38:165-168,1999.

6. Saitoh, I., Haruta, K., Shimura, M., Inoue, H., Sakurai, H., Yamada, K., Ishimaru, N., Higashiyama, H., Sumida, T., Ishida, H., Suda, T., Noda,T., Hayashi, Y., and Tsubota, K. Fas-ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J. Immunol. 162:2488-2494, 1999.

7. Usui, J., Takemura, H., Yuhara, T., Akama, T., Suzuki, H., Yamane, K., and Sumida, T. Dieulafoy's lesion of the esophagus as a probable complication of Takayasu's arteritis. J. Rheumatol. 26: 454-456, 1999.

8. Suzuki, M., Katsube, Y., Suzuki, H., Takemura, H., and Sumida, T. Cloning and analysis of anti-double strand DNA IgG autoantibodies obtained by a phage-display method. Int. J. Mol. Med. 3:385-390, 1999.

9. Keino, H., Matsumoto, I., Okada, S., Kurokawa, M., Kato, T., Tokuhisa, T., Taniguchi, M., Nishioka, K., and Sumida, T. A single cell analysis of TCR AV24AJ18+ DN T cells. Microbiol. Immunol. 43:577-584, 1999.

10. Matsumoto, I., Maeda, T., Takemoto, Y., Hashimoto, Y., Kimura, F., Iwamoto, I., Saito, Y., Nishioka, K., and Sumida, T. a-amylase function as salivary glands-specific self T cell epitopes in patients with Sjogren's syndrome. Int. J. Mol. Med. 3:485-490, 1999.

11. Murata, H., Nakauchi, H., and Sumida, T. Microchimerism in Japanese women patients with systemic sclerosis. Lancet. 354:220,1999.

12. Kitagawa, M., Mitsui, H., Nakamura, H., Yoshino, S., Miyakawa, S., Ochiai, N., Onobori, M., Suzuki, H., and Sumida, T. Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals. Arthritis Rheum. 42:1917-1926, 1999.

13. Akimoto, T., Akama, T., Kono, I., and Sumida, T. Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome. LUPUS 8:761-766, 1999.

14. Matsumoto, I., Okada, S., Kuroda, K., Iwamoto, I., Saito, Y., Tokuhisa, T., Nishioka, K., Sumida, T. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. Int. J. Mol. Med. 4:519-527, 1999.


1998年
1. Katsube, Y., Suzuki, H., Muryoi, T., Sasaki, T. Analysis of k light chain contribution to anti-DNA antibody activity of a human VH4-21-encoded monoclonal antibody(NE-1) by antibody-phage display technique. Int. J. Mol. Med. 1:863-868, 1998.

2. Nishioka, K., Hasunuma, T., Kato, T., Sumida, T., and Kobata, T. Apoptosis in theumatoid arthritis: A novel pathway in regulation of synovial tissue (Review). Arthritis Rheum. 41:1-9, 1998.

3. Fujisawa, K., Okamoto, K., Murata, H., Hasunuma, T., Sumida, T., and Nishioka, T. Evidence for autoantigens of env/tax proteins in HTLV-I tax transgenic mice. Arthritis Rheum. 41:101-109, 1998.

4. Sumida, T., Hasunuma, T., Asahara, H., Maeda, T., and Nishioka, K. Rheumatoid arthritis and apoptosis (Review). Int. Med. 37:184-188, 1998.

5. Okamoto, K., Asahara, H., Kobayashi, T., Matsuno, T., H, Hasunuma., T, Kobata., T, Sumida., and Nishioka, K. Potential Induction of apoptosis in rheumatoid synovium by FAS ligand gene transfer. Gene Therapy. 5:331-338, 1998.

6. Kita, Y., Kuroda, K., Mimori, T., Hashimoto, T., Tananiti, K., Saito, Y., Iwamoto, I., and Sumida, T. T cell receptor clonotypes in skin lesions From Patientswith systemic lupus erythematosus. J. Investi. Dermatol. 110:41-46, 1998.

7. Maeda, T., Webb, D.R., Kobata, T., Hirsose, S., Shirai, T., Nishioka, K., and Sumida, T. Deletion of signaling molecule gene resembling the cytoplasmic domain of Igb in autoimmune prone mice. Int. Immunol. 6:815-821, 1998.

8. Takemura, H., Suzuki, H., Fujisawa, H., Yuhara, T., Akama, T., Yamane, K., and Kashiwagi, H. Enhanced IL-6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet-derived growth factor (PDGF). J. Rheumatol. 25:1534-1539, 1998.

9. Kaneko, S., Nagata, M., Takemura, H., Yuhara, T., Akama, T., Suzuki, H., Yamane, K., Kashiwagi, H. Gelatinous transformation of bone marrow with pancypeniai n an emaciatedpatient with systemic lupus erythematosus. Jpn. J. Rheumatol. 8:167-173, 1998.

10. Imamura, F., Aono, H., Hasunuma, T., Sumida, T., Tateishi, H., Maruo, S., and Nishioka, K. Monoclonality of synoviocytes are responsible for rapid progression of bone destruction in rheumatoid arthritis. Arthritis. Rheum. 41:1979-1986, 1998.

11. Matsumura, R., Umemiya, K., Kagami, M., Tomioka, H., Tanebe, E., Sugiyama, T., Sueishi, M., Nakajima, A., Azuma, M., Okumura, K., and Sumida, T. Glandular and Extraglandular expression of Fas-Fas ligand and apoptosis in patients with sjogren's syndorome. Clin. Exp. Rheumatol. 16:561-568, 1998.

12. Sumida, T., Maeda, T., Taniguchi, M., Nishioka, K., and Stohl, W. TCR AV24 Gene Expression in Double Negative T Cells in Systemic Lupus Erythematosus. Lupus 7:565-568, 1998.

13. Hasunuma, T., Sumida, T., and Nishioka, K. Human T cell leukemia virus type-1 and rheumatoid arthritis. Int. Rev. Immunol. 17:291-307, 1998.